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Summary 13 
The type VII protein secretion system (T7SS) plays a critical role in the virulence of human 14 
pathogens including Mycobacterium tuberculosis and Staphylococcus aureus. Here we report 15 
that the S. aureus T7SS secretes a large nuclease toxin, EsaD. The toxic activity of EsaD is 16 
neutralised during its biosynthesis through complex formation with an antitoxin, EsaG, which 17 
binds to its C-terminal nuclease domain. The secretion of EsaD is dependent upon a further 18 
accessory protein, EsaE, that does not interact with the nuclease domain, but instead binds 19 
to the EsaD N-terminal region. EsaE has a dual cytoplasmic/membrane localization and 20 
membrane-bound EsaE interacts with the T7SS secretion ATPase, EssC, implicating EsaE in 21 
targeting the EsaDG complex to the secretion apparatus. EsaD and EsaE are co-secreted 22 
whereas EsaG is found only in the cytoplasm and may be stripped off during the secretion 23 
process. Strain variants of S. aureus that lack esaD encode at least two copies of EsaG-like 24 
proteins most likely to protect themselves from the toxic activity of EsaD secreted by esaD+ 25 
strains. In support of this, a strain overproducing EsaD elicits significant growth inhibition 26 
against a sensitive strain. We conclude that T7SSs may play unexpected and key roles in 27 
bacterial competitiveness. 28 
 29 
Protein secretion systems are used by bacteria to interact with and manipulate their 30 
environments, and play critical roles in the secretion of virulence factors. Gram-negative 31 
bacteria produce numerous secretion systems that transport substrates across the cell 32 
envelope1. Many Gram-positive bacteria also produce a specialised protein secretion 33 
machinery termed the Type VII secretion system (T7SS). T7SSs are found in representatives 34 
of the Actinobacteria and Firmicutes phyla. The system was first described in the 35 
Actinobacterial pathogens Mycobacterium tuberculosis and M. bovis where T7SS ESX-1 was 36 
shown to be essential for virulence and to secrete two small proteins ESAT-6 and CFP-10, 37 
subsequently renamed EsxA and EsxB2-4. In addition to secreting EsxA/B proteins, 38 
Mycobacterial T7SSs can also secrete much larger proteins of the PE/PPE family5, which are 39 
highly abundant in the genomes of some species6.  40 
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A distantly related T7SS, termed T7b7, is also found in Firmicutes such as Bacillus subtilis8,9 41 
and Staphylococcus aureus10. T7SSs share two common types of components: a membrane-42 
bound hexameric ATPase of the FtsK/SpoIIIE protein family11,12 and at least one EsxA/EsxB-43 
related protein11. EsxA and EsxB are members of the WXG100 superfamily that form dimeric 44 
helical hairpins13,14, and in Firmicutes EsxA is exported as a folded homo-dimer14,15. The S. 45 
aureus Ess system comprises six core components10,16 (Figs 1A; S1). In addition to EssC, 46 
three further membrane proteins EsaA, EssA, EssB are essential for T7 secretion activity16,17 47 
along with the secreted protein EsxA10 and the predicted cytoplasmic protein EsaB16. All 48 
except one strain of S. aureus examined to date encode the six core T7 components but there 49 
is strain variability in the repertoire of T7 substrate proteins18. Studies using strains with the 50 
NCTC8325 T7S gene cluster organisation, including Newman, USA300 and RN6390 have 51 
identified EsxB, EsxC and EsxD as secreted substrates10,16,19,20. These three proteins are 52 
small (~100-130 aa), and their precise functions remain to be elucidated.   53 
The T7SS has previously been shown to contribute to virulence in mouse infection 54 
models10,16,21 and to facilitate release of intracellular S. aureus from epithelial cells22. Here we 55 
identify a further function for the S. aureus T7SS in bacterial competition. We show that EsaD 56 
is a T7 nuclease substrate that interacts with two Ess accessory proteins, EsaG, an antitoxin, 57 
and EsaE, a putative chaperone, during its biosynthesis. Strains of S. aureus that do not 58 
encode the EsaD substrate harbour esaG homologues, most likely to protect themselves from 59 
killing by EsaD-producing strains. In support of this we demonstrate EsaD-dependent growth 60 
inhibition of S. aureus. Our findings confirm that the Gram-positive T7SS has anti-bacterial 61 
activity in addition to anti-eukaryotic function. 62 
 63 
Results 64 
EsaD is not required for T7SS activity. EsaD is encoded within the T7SS gene cluster (Fig 65 
1a) and has been reported to be a membrane-bound T7SS accessory factor23, however its 66 
absence from some S. aureus strains indicates it is unlikely to be a critical component of the 67 
secretion machinery18. We constructed an in-frame esaD deletion and asked whether it was 68 
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required for secretion of the core component EsxA and the substrate protein EsxC. Fig 1b 69 
shows that EsxA was still secreted by the esaD strain, but very little EsxC was detected. To 70 
circumvent this we overproduced EsxC from a plasmid (Fig 1c), and in this case could clearly 71 
detect EsxC in culture supernatants of the esaD strain. We conclude that EsaD is not essential 72 
for T7-dependent secretion.  73 
EsaD is a predicted nuclease that is secreted by the T7SS. EsaD encoded by strain 74 
NCTC8325 is predicted to be a 614 residue protein, and sequence analysis suggests that the 75 
C-terminal ~170 aa comprise a nuclease domain (Fig S2). In accord with EsaD having toxic 76 
activity, we were unable to clone esaD unless we introduced a H528A codon substitution at 77 
the predicted nuclease active site. When HA-tagged EsaD(H528A) was produced in either S. 78 
aureus RN6390 or COL strains, tagged protein was detected in the supernatant (Fig 1d, e). 79 
The lack of EsaD in supernatants of the cognate essC strains strongly suggests that EsaD is 80 
a T7SS secreted substrate. 81 
EsaD has previously been reported as a membrane protein23. However, topology prediction 82 
programmes (e.g. TMHMM) do not predict transmembrane regions. To explore the location of 83 
cellular EsaD we fractionated cells producing EsaD(H528A)-HA and Fig 1f shows the tagged 84 
protein (migrating as a double band) was clearly detected only in the cytoplasmic fraction. We 85 
conclude EsaD is not a membrane protein. 86 
EsaD has toxic activity that is neutralised by EsaG. To confirm that EsaD is a toxin, it was 87 
essential to clone the wild-type gene. We could readily clone esaD if the downstream gene, 88 
esaG, was included, but not if this sequence was omitted. We were eventually able to obtain 89 
a clone of esaD in pT7.524. Expression of genes from this vector is under control of the T7 90 
promoter which is not recognised by E. coli RNA polymerase. Even so, the clone we obtained, 91 
which gave very small colonies, harboured a V584Y substitution. We reasoned that this might 92 
serve to lower the stability/toxicity of EsaD. When this construct was introduced into E. coli 93 
BL21(DE3) (that encodes an inducible copy of the phage T7 RNA polymerase), growth ceased 94 
when the inducer, IPTG was added (Fig 2a) but cells continued to grow if esaG was co-95 
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expressed with wild type esaD. We conclude that EsaD has toxic activity that is modulated by 96 
EsaG. 97 
Examination of E. coli cells by microscopy showed that production of EsaD(V584Y) resulted 98 
in cell elongation (Fig S3a,b), a hallmark of the SOS response induced by DNA damage25,26, 99 
consistent with EsaD exhibiting DNase activity. We confirmed EsaD-induced DNA damage 100 
using TUNEL, which labels the ends of fragmented DNA27,28. Fluorescence microscopy 101 
showed TUNEL staining in a subset of cells producing EsaD(V584Y) (Fig S3c) that could also 102 
be detected by flow cytometry (red dots in FACS plot in Fig S3d). Production of EsaD was 103 
also associated with an increase in side scatter, consistent with changes in cellular 104 
morphology seen by microscopy. We conclude that EsaD results in DNA damage when 105 
produced in the cytoplasm of E. coli.  106 
EsaG interacts with the nuclease domain of EsaD. The presence of esaG counteracts the 107 
toxic activity of EsaD suggesting that esaG is an antitoxic gene. Antitoxins may be proteins or 108 
RNA29. Inspection of esaG indicates that it is a probable protein-coding gene, producing a 109 
protein of the uncharacterised DUF600 family. To investigate whether EsaG interacts with 110 
EsaD we co-produced EsaD(H528A)-His with EsaG-HA in S. aureus and purified tagged EsaD 111 
from cell lysates. Fig 2c shows that EsaG co-purifies with EsaD indicating the proteins form a 112 
complex. 113 
EsaD-EsaG interaction was also confirmed by bacterial two hybrid assay (Fig 2b). EsaG (163 114 
aa) is significantly smaller than EsaD, suggesting it may interact with only part of EsaD. We 115 
genetically separated EsaD into predicted nuclease domain (EsaD421-614, harbouring the 116 
H528A codon substitution) and N-terminal region (EsaD1-420). Fig 2b shows that EsaG 117 
interacts specifically with the predicted nuclease domain. This was confirmed biochemically 118 
by co-purification of EsaG-HA with His-tagged EsaD421-614 (Fig 2d). We conclude that EsaG is 119 
a proteinaceous antitoxin that blocks EsaD activity by direct interaction. 120 
To investigate directly whether EsaD has DNase activity, we overproduced His-tagged wild 121 
type or H528A variants of the nuclease domain in E. coli in the presence of EsaG and purified 122 
His-tagged EsaD in the presence of 8M urea to unfold the protein and detach bound EsaG 123 
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(Fig 2e). After refolding and eluting from the Ni-resin, the EsaD nuclease domains were 124 
incubated with plasmid DNA in the presence of Mg2+ or Zn2+ ions. Fig 2f shows that wild type 125 
EsaD specifically degraded plasmid DNA in the presence of Mg2+,and could also degrade 126 
genomic and linear DNA (Fig S5). The H528A variant showed some DNAse activity, but 127 
appeared to be much less potent than EsaD, as expected. We conclude that EsaD is a Mg2+-128 
dependent DNase. 129 
Fractionation of cells overproducing tagged EsaG shows that it is found exclusively in the 130 
cytoplasm (Fig S6). However, as the T7SS can export protein complexes15, we tested whether 131 
it could be co-secreted if overproduced with EsaD. Fig S7 shows that in the presence of 132 
secreted EsaD(H528A), EsaG localised only to the cell fraction and does not appear to be co-133 
secreted with its partner protein. We then asked whether EsaG was required for secretion of 134 
EsaD. We were not able to delete esaG from S. aureus unless we also deleted esaD, 135 
consistent with its antitoxic role. Production of HA-tagged EsaD(H528A) in the esaDG mutant 136 
strain resulted in no detectable EsaD in the supernatant and very little in the cells (Fig S8). 137 
We conclude that EsaG is required for the stability/secretion of EsaD. EsaG was not, however, 138 
required for the secretion of either EsxA or EsxC (Fig S9) and is therefore not a general T7S 139 
accessory factor.   140 
EsaE also interacts with EsaD and is required for its secretion or stability. Studies of 141 
Mycobacterial T7SS have revealed that PE/PPE substrate proteins interact with specific 142 
chaperones that facilitate their secretion30-32. To investigate whether any additional soluble 143 
proteins encoded at the S. aureus T7SS locus interact with EsaD, we used bacterial two hybrid 144 
analysis. Fig 3a shows no evidence for EsaD interaction with any known secretion substrates 145 
(EsxB, EsxC or EsxD) or soluble machinery components (EsaB or EsxA). Interaction was 146 
detected between EsaD and EsaE, which was also confirmed biochemically as EsaE-HA co-147 
purified with EsaD(H528A)-His when the two proteins were co-produced in S. aureus (Fig 3b). 148 
To determine whether EsaE interacted with the nuclease domain of EsaD or elsewhere on the 149 
protein, we screened EsaE interaction with EsaD1-420 or EsaD421-614(H528A) (Fig 3c). The 150 
results show that EsaE specifically interacts with the non-nuclease region of EsaD. We tried 151 
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to confirm these genetic observations with co-purification experiments but were not able to 152 
stably produce the truncated EsaD1-420.  153 
We constructed an in-frame deletion of esaE to determine whether it was required for EsaD 154 
secretion. We were readily able to obtain the esaE mutant, consistent with EsaE not being an 155 
antitoxin but playing some other role in EsaD biosynthesis. Production of HA-tagged 156 
EsaD(H528A) in this strain resulted in no detectable EsaD in the supernatant and very little in 157 
the cells (Fig S8), suggesting EsaE is required for its stability or secretion. Although EsaE was 158 
not required for EsxA secretion, there was no apparent secretion of EsxC in the esaE mutant, 159 
even if EsxC was overproduced from a plasmid (Fig S9). Thus EsaE is required for efficient 160 
secretion of EsaD and at least one further T7SS substrate. 161 
His-tagged EsaE was found almost exclusively in the cellular fraction, suggesting it is not, by 162 
itself, a T7SS substrate (Fig 3d). We did, however, routinely observe that overproduction of 163 
tagged EsaE led to a dramatic increase in the level of extracellular EsxA (Fig 3d), for reasons 164 
that are unclear. However, when EsaE-His was co-produced with EsaD(H528A)-HA, notable 165 
secretion of His-tagged EsaE could now be detected suggesting that these two proteins are 166 
co-exported as a complex. 167 
EsaD/E/G form a ternary complex. We next assessed whether EsaD could form a ternary 168 
complex with EsaE and EsaG. Control experiments (Fig S10) showed no direct interaction 169 
between EsaE and EsaG by either two hybrid or co-purification experiments. When 170 
EsaD(H528A)-Myc, EsaE-HA and EsaG-His were co-produced in E. coli and EsaE-HA 171 
immunoprecipitated, EsaG-His and Myc-tagged EsaD were also co-precipitated, consistent 172 
with the three proteins forming a ternary complex (Fig 3f,g). Reciprocal experiments where 173 
His-tagged EsaG was isolated by Ni-affinity purification resulted in co-purification of EsaE-HA 174 
and EsaD-Myc (Fig S12). In this latter experiment, although some full length EsaD-Myc was 175 
detected, most of the protein was fragmented to the approximate size of the nuclease domain, 176 
consistent with the prior instability of EsaD1-420 noted previously.  177 
EsaE interacts with the multimeric form of EssC. Although EsaE is predicted to be soluble, 178 
subcellular fractionation showed a proportion of His-tagged EsaE localised to the membrane 179 
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and was stable to carbonate washing (Fig 4a). As EsaE has a dual cytoplasmic-membrane 180 
location, we wondered whether it may play a role in targeting EsaD/EsaG to the membrane-181 
bound secretion machinery. We undertook formaldehyde crosslinking experiments in whole 182 
cells of S. aureus producing EsaE-His, isolated membranes and blotted for EsaE. Fig 4b 183 
shows several EsaE-His crosslinks, including a particularly strong crosslink migrating above 184 
250 kD. It has previously been shown that the S. aureus T7 ATPase, EssC, forms a high 185 
molecular weight multimer17,33. To ascertain whether this high molecular weight crosslink also 186 
contained EssC, we repeated the crosslinking experiments in the wild type and essC mutant 187 
strains. Fig 4c shows that the EsaE-His-containing crosslink migrated with an apparently 188 
identical mass as the EssC-containing crosslink and moreover, no such crosslink was 189 
detected when essC was deleted. We conclude that the membrane-bound form of EsaE 190 
interacts with the multimeric form of EssC.     191 
These results suggest a model for the biosynthesis and secretion of EsaD (Fig 4d), whereby 192 
the interaction of EsaG and EsaE with their respective binding domains on EsaD is essential 193 
for maintaining EsaD in a catalytically-inactive, secretion-competent conformation. Our 194 
findings support the idea that targeting of the protein complex to the T7 secretion machinery 195 
is by virtue of the interaction between EsaE and the assembled EssC multimer and that EsaG 196 
is stripped from the complex at some point during secretion and remains in the cytoplasm. 197 
Thus EsaD is released from the cell in a form that is immediately active, and the EsaG 198 
immunity protein remains in the producing cell where it may potentially serve further protective 199 
functions. 200 
Secreted EsaD inhibits the growth of sensitive strains of S. aureus. We next addressed 201 
potential roles for EsaD. Gram-negative bacteria utilise a subset of their protein secretion 202 
systems to target toxins at bacterial competitors as well as at eukaryotic cells34-38. It was noted 203 
previously that although approximately 50% of S. aureus strains do not carry esaD, they 204 
encode at least two homologues of esaG close to their T7SS gene clusters18 (Fig 5a) 205 
suggesting they may produce EsaG-type proteins as a protective mechanism to prevent killing 206 
by EsaD-producing strains. To probe this, we assessed whether EsaG homologues from non 207 
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esaD-containing strains MRSA252, ST398 and EMRSA15 could interact with EsaD(H528A) 208 
using two hybrid analysis. At least one EsaG homologue from each strain was able to interact 209 
with EsaD (Fig 5b), supporting the idea that orphan EsaG proteins serve to protect S. aureus 210 
from EsaD nuclease toxins. 211 
A common feature of bacterial toxins, particularly those involved in interspecies competition, 212 
is that that they are polymorphic39,40. Comparison of EsaD sequences across esaD-encoding 213 
S. aureus strains shows extensive sequence variability within the nuclease domain but away 214 
from the predicted catalytic site (centred around H528; Fig S13). A likely explanation is that 215 
substitutions in this region of EsaD alter affinity for a cognate EsaG antitoxin and render 216 
normally resistant strains susceptible to attack by EsaD sequence variants. In this context it is 217 
interesting to note a cluster of EsaG homologues are encoded directly downstream of esaDG 218 
in S. aureus esaD-containing strains that is highly variable in number18. For example 219 
NCTC8325 encodes five of these (Fig 5a), whereas COL encodes eleven. These genes are 220 
not co-transcribed with esaDG in strain RN6390 (Fig S14), however analysis of RNA-seq data 221 
from18 indicated that transcripts from these genes are present under laboratory growth 222 
conditions. 223 
We could readily delete the cluster of esaG-like genes from RN6390 indicating they are not 224 
required to neutralise EsaD, consistent with our prior conclusion that EsaG itself is the cognate 225 
EsaD antitoxin. Loss of this esaG-like gene cluster, or indeed absence of all EsaG-encoding 226 
proteins (including EsaG) also did not affect the secretion of EsxA or EsxC (Fig S9) confirming 227 
these proteins are not essential components of the T7SS machinery. However, two hybrid 228 
assay shows that they are able to interact with EsaD (Fig 5c), but that the interaction is not as 229 
strong as that seen for EsaD-EsaG, raising the possibility that they serve to protect RN6390 230 
from EsaD sequence variants produced by other strains of S. aureus. 231 
Together, the results presented above strongly suggest that S. aureus uses its T7SS to 232 
secrete a nuclease toxin that targets rival bacteria. To confirm this, we used S. aureus strain 233 
COL, which shows the highest level of T7S activity in laboratory growth media16 producing 234 
plasmid-encoded EsaDG as attacker, and incubated it with variants of strain RN6390. Fig 5d 235 
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shows that there is an approximate two-log decrease in recovered prey cells when they are 236 
co-cultured with a T7SS+ strain of COL compared with a T7SS mutant strain, demonstrating 237 
there is T7-dependent growth inhibition. Importantly, this is completely dependent upon the 238 
toxic activity of EsaD as COL producing the H528A variant of EsaD no longer exhibited 239 
detectable growth inhibition (Fig 5d). Finally, as expected, EsaG offered some protection 240 
against the inhibitory effect of secreted EsaD as the RN6390 wild type tended to be less 241 
susceptible to EsaD-dependent growth inhibition than a strain lacking EsaG homologues, and 242 
the protective effect was enhanced by overproduction of plasmid-encoded EsaG in the prey 243 
cells. We conclude that S. aureus can use its T7SS to target bacterial competitors. 244 
 245 
Discussion 246 
It is well established that T7SSs play critical roles in mammalian infection and virulence. Here 247 
we demonstrate an important novel role for the S. aureus T7SS in the secretion of a nuclease 248 
toxin, EsaD, involved in interspecies competition. Thus, akin to the Gram-negative Type VI 249 
secretion system34,41, the T7SS appears to target eukaryotes and rival bacteria. 250 
EsaD is the largest known substrate of the T7b system and the only one for which a function 251 
has been identified. We have shown that two T7 accessory factors are essential for the 252 
biogenesis of EsaD - EsaG that binds to and neutralises the toxic activity of the nuclease 253 
domain and EsaE that interacts with, and potentially stabilises, the N-terminal region. In this 254 
context it is interesting to note that large substrates of the Mycobacterial T7a system such as 255 
the PE/PPE proteins interact with specific chaperones of the EspG family that keep them in a 256 
secretion-competent state32 and deliver them to the cognate secretion machinery31. Although 257 
there is no detectable sequence similarity between EspG proteins and EsaE, it is possible that 258 
the proteins have analogous functions in the two distantly related secretion machineries. 259 
The presence of T7SSs in non-pathogenic organisms such as Streptomyces coelicolor42 and 260 
Bacillus subtilis8,9 has previously been noted. Here we offer a likely explanation for the 261 
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presence of this secretion system in environmental strains. We have demonstrated that 262 
secreted EsaD inhibits the growth of sensitive strains of S. aureus, indicating this nuclease 263 
toxin is used to target competitor bacteria. In support, strains of S. aureus lacking esaD encode 264 
at least two copies of the EsaG-like antitoxin, presumably as a protective mechanism. It is 265 
interesting to note that an EsaD homologue has been reported in B. subtilis23 that likely has 266 
toxic activity43, inferring that modulating bacterial competition is a conserved role for T7SSs.  267 
It is currently not known how EsaD accesses the cytoplasm of target cells. There is no 268 
evidence that T7SSs form large extracellular needle-like structures that could deliver toxins 269 
directly into target cells, like to those seen for the Gram-negative Type III, IV and VI secretion 270 
systems1. Instead we suggest that EsaD is released into the environment where it binds to 271 
receptors on sensitive cells in a similar manner as bacteriocins and contact-dependent growth 272 
inhibition (CDI) toxins, as the first step in a cell entry pathway44,45. Further work will be required 273 
to dissect out the mechanism by which EsaD interacts with and traverses the cell envelope of 274 
S. aureus. 275 
S. aureus is an important pathogen in polymicrobial human infections, for example infections 276 
of the skin and lung. Whether EsaD-mediated interspecies competition is critical for the 277 
establishment of virulence in animal and human infections and whether there are additional 278 
antibacterial toxins secreted by the S. aureus T7SS remain to be established.  279 
 280 
Methods 281 
Bacterial strains and growth conditions: Strains and plasmids used in this study are listed 282 
in Tables S1 and S2. S. aureus strains were grown in TSB medium at 37°C under vigorous 283 
agitation. Where required, chloramphenicol (Cm) at a final concentration of 10 µg/ml was 284 
added for plasmid selection. Anhydrotetracycline (ATC) was used as a selection during allelic 285 
gene replacement using the pIMAY system (1 µg/ml46) or for induction of target gene 286 
expression from the pRAB11 plasmid47; the concentrations used in each experiment are listed 287 
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in the appropriate figure legends). Escherichia coli was grown aerobically in Lysogeny broth 288 
(LB) at 37°C. If required, cultures were supplemented with ampicillin (Amp, 100 µg/ml), 289 
Kanamycin (Kan, 50µg/ml) or Cm (15 µg/ml) for plasmid selection. Induction of plasmid-290 
encoded gene expression was achieved by addition of isopropyl--D-galactopyranoside 291 
(IPTG), as indicated in the text. Light microscopy was carried out using a Zeiss 292 
light/fluorescence microscope with a 100x oil objective and images captured using an AXIO 293 
camera (Zeiss). The light microscopy images in Fig S3a were performed twice using different 294 
biological samples, representative images are shown. Bacterial two-hybrid analyses were 295 
performed as described48; quantitative assessment of protein interactions was undertaken by 296 
plating onto MacConkey medium49 containing 0.4% maltose as carbon source, and quantified 297 
by β-galactosidase assays (according to the method of50) on strains grown to exponential 298 
phase at 30°C and permeabilized with toluene. For all of the bacterial two hybrid experiments 299 
reported (Figs 2b, 3a, 3c, 5b, 5c, S10a) each interaction pair was scored on MacConkey 300 
maltose on at least four different occasions and β-galactosidase assays were performed at 301 
least twice, and representative results are presented. RT-PCR was undertaken on RNA 302 
prepared from S. aureus strain RN6390 grown aerobically in TSB to an OD600 of 2, as 303 
described previously16 using primer pairs listed in Table S3, and was performed twice (on the 304 
same biological sample – results presented in Fig S14b are representative). 305 
Strain and plasmid construction: All oligonucleotide primers used in this study and cloning 306 
strategies to generate the strains and plasmids are outlined in Table S3. In-frame deletions of 307 
S. aureus genes were performed by allelic exchange using pIMAY46. For each gene, the 308 
upstream and downstream regions including at least the first three and last three codons were 309 
amplified from RN6390 genomic DNA using primers listed in Table S3. Clones were selected 310 
in E. coli, verified by DNA sequencing and introduced into S. aureus RN6390 strains by 311 
electroporation. Chromosomal deletions were verified by amplification of the genomic region 312 
from isolated genomic DNA (GeneElute Bacterial Genomic DNA Kit, Sigma Aldrich) and DNA 313 
sequencing of the amplified products.  314 
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To construct strains specifying chromosomally-encoded erythromycin resistance, the 315 
erythromycin resistance gene, ermC, was integrated into the RN6390 genome after base pair 316 
14208 as this region was found to be devoid of transcriptional activity in the closely related 317 
strain NCTC 8325-451. A synthetic construct comprising ermC from Staphylococcus lentus 318 
plasmid pSTE2 under control of the rpsF promoter from Bacillus subtilis (purchased from 319 
Biomatik; sequence given in Fig S16) was cloned into pIMAY and integrated into the 320 
chromosome giving RN6390::ermC. Integration of the resistance gene was confirmed by 321 
sequencing and by testing for growth in the presence of 5 µg/ml erythromycin. Subsequently 322 
the ermC cassette was transduced from RN6390::ermC into other strains using phage ɸ11 as 323 
described52. Transduction was confirmed by PCR amplification using oligonucleotides Intctrl1 324 
and Intctrl2 (Table S3). 325 
Bacterial competition experiments: Overnight cultures of the indicated strains were 326 
subcultured in TSB (supplemented with 2M hemin for attacker strains) and antibiotics as 327 
required and cultured with shaking at 37°C. Once OD600 of 0.5 was reached, induction of 328 
EsaD-HA and EsaG-His production in the attacker strains was initiated by the addition of 500 329 
ng/ml of ATC. When cells reached OD600 of 2, 20ml of attacker strain, and 1ml of prey were 330 
separately harvested and resuspended in 1ml of TSB. 100ul of resuspended attacker cells 331 
were mixed with the same volume of prey cells (giving a 20:1 ratio) and incubated at 37°C 332 
with shaking for 16 h in sterile Eppendorf tubes. Co-cultures were then serially diluted in TSB 333 
and plated on selective agar (LB + 5 µg/ml erythromycin as all prey strains carried 334 
chromosomally-integrated ermC conferring resistance to erythromycin) for colony-forming unit 335 
determination. For experiments where plasmid-encoded EsaG-His was produced in prey cells, 336 
once strain RN6390 pEsaG-His reached an OD600 of 0.5, EsaG-His production was initiated 337 
by the addition of 250 ng/ml of ATC and cultured until an OD600 of 2 was reached after which 338 
they were used as prey as described above.  339 
TUNEL assay for DNA fragmentation: DNA fragmentation was detected in fixed cells of E. 340 
coli BL21(DE3) harbouring pT7.5esaD and pT7.5esaDG using the Deadend fluorometric 341 
TUNEL system kit (Promega). This was undertaken on two biological replicates and 342 
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representative results are shown in FigS3 c and d. Following induction of EsaD production by 343 
treating cell cultures with 1mM IPTG for 3 hours, cells were pelleted, washed twice with PBS 344 
and fixed with 4% formaldehyde in PBS for 30 minutes on ice. Following a further wash with 345 
PBS, cells were permeabilized with 1.5% triton X-100 solution in PBS for 1 hour on ice and 346 
stored in 70% ice cold ethanol at -20 ⁰C overnight. The following day cells were spun down, 347 
washed and resuspended in equilibration buffer for 1 hour at 37⁰C. The cells were incubated 348 
in the dark for 2 hours with fluorescein 12-dUTP and recombinant terminal deoxynucleotidyl 349 
transferase (rTdT), after which the reaction was quenched by addition of 2x SCC buffer, and 350 
the cells washed with PBS. Following this fluorescein-labelled cells were spotted onto poly-D-351 
lysine-treated slides and analysed by fluorescence microscopy using a Zeiss fluorescence 352 
microscope with a 100x oil objective and images captured using an AXIO camera (Zeiss), or 353 
detected and quantitated directly by flow cytometry (Flow cytometry Facility, Dundee 354 
University).  Negative control samples were treated identically except that no rTdT was added.  355 
Purification of the EsaD nuclease domain: E. coli strain M15[prep4] harbouring pQE70-356 
EsaG-EsaG-EsaD421-614-His or pQE70-EsaG-EsaG-EsaD421-614(H528A)-His was cultured to 357 
OD600 of 0.5 at 37ºC, after which 1mM IPTG was added to each culture. An aliquot of the cells 358 
were harvested after 4 hours induction and resuspended in lysis buffer and the remainder of 359 
the cells were pelleted and frozen at -80°C for 30 mins. The nuclease domain of EsaD was 360 
subsequently purified following a protocol based on that described at 361 
http://openwetware.org/wiki/Knight:Purification_of_His-362 
tagged_proteins/Denaturing_with_refolding with some modifications, and was undertaken 363 
once for each variant (Fig 2e). Briefly, the thawed pellets were resupended in lysis buffer (8 M 364 
Urea, 100 mM NaH2PO4, 10mM Tris·HCl, 10mM imidazole, 1 mM PMSF, pH 8.0) and 365 
sonicated for 2 mins on ice. The cell lysate was centrifuged at 13,200 × g for 30 min at 4 °C. 366 
Nickel affinity resin (Biorad) was equilibrated with lysis buffer and added to the cleared lysate 367 
and gently mixed on a rotary shaker for 2 h at 4 °C. The resin was washed five times with 368 
denaturing wash buffer (8 M Urea, 100 mM NaH2PO4, 150mM NaCl, 20mM imidazole, 1 mM 369 
PMSF, pH 8.0) followed by five washes with native wash buffer (50 mM NaH2PO4, 500mM 370 
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NaCl, 20mM imidazole, 1 mM PMSF, pH 8.0). Finally, the bound protein was eluted into 200 371 
l of elution buffer (50 mM NaH2PO4, 500mM NaCl, 250mM imidazole, 1 mM PMSF, pH 8.0).  372 
For nuclease assays, 800 ng of plasmid pT18 was incubated with 0.4 µg of purified EsaD421-373 
614-His, purified EsaD421-614(H528A)-His or an equivalent volume of elution buffer at 37°C for 1 374 
hour in a final volume of  20l the presence of either 50mM MgCl2 or ZnCl2 as indicated, after 375 
which the DNA was analysed by agarose gel electrophoresis. These assays were each 376 
performed three times and representative results are presented in Figs 2f and S5. 377 
Cell fractionation, crosslinking and western blotting: For the isolation of cell and 378 
supernatant fractions to assess secretion activity, S. aureus strains were subcultured at 1/100 379 
from an overnight grown pre-culture into fresh TSB medium. At OD600nm of 2, cells were 380 
harvested and the supernatant samples precipitated with trichloroacetic acid in the presence 381 
of deoxycholate, as described previously16. Harvested cell samples were washed once with 382 
PBS buffer, normalized to an OD600 of 2 in PBS and lysed by addition of 50 µg/ml lysostaphin 383 
with incubation at 37°C for 30 min. All samples were mixed with an equal volume of LDS buffer 384 
and boiled for 10 min prior to analysis. For the secretion experiments shown in Fig 1b, 1c, 1e, 385 
S9a, S9b and S14 representative images are shown from at least two biological replicates, 386 
and in Figs 1d, 3d, 3e, S7 and S8 representative images are shown from at least six biological 387 
replicates. The fractionation of cells to give cell wall, membrane and cytoplasmic fractions was 388 
undertaken as described by16. Carbonate-washing of membranes was undertaken according 389 
to53. All fractionation experiments (Figs 1f, 3a and S6) were undertaken at least twice on 390 
separate biological samples, with representative results presented. 391 
Formaldehyde crosslinking of cells was undertaken as described previously17 and crosslinking 392 
experiments were performed twice on separate biological samples – the results presented in 393 
Fig 3b and c are representative results. Western blotting was performed according to standard 394 
protocols using the following antibody dilutions: α-EsxA16 1:2500, α-EsxC16 1:2000, α-EssC16 395 
1:10000, α-TrxA54 1:25000, α-SrtA (Abcam, catalogue number ab13959) 1:3000, α-HA (HRP-396 
conjugate, Sigma catalogue number H6533) 1:10000, α-His (HRP-conjugate, Abcam 397 
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catalogue number ab184607) 1:10000, α-Myc (HRP-conjugate, Invitrogen catalogue number 398 
R951-25) 1:5000, and goat anti Rabbit IgG HRP conjugate (Bio-Rad, catalogue number 170-399 
6515) 1:10000. 400 
Protein purification by nickel affinity isolation or immunoprecipitation: Cells of E. coli or 401 
S. aureus, grown as described in the figure legends, were harvested and resuspended in 402 
either ice cold (i) resuspension buffer (200 mM NaCl, 20 mM HEPES, pH 7.2) for Ni affinity 403 
purification or (ii) phosphate-buffered saline (PBS) for immunoprecipitation. Samples were 404 
then supplemented with a few flakes of DNase I, 1 mM PMSF and either lysozyme (for E. coli) 405 
or lysostaphin (for S. aureus). The samples were incubated at 37oC for 0.5-1 hour with gentle 406 
mixing on a rotating wheel after which cells were lysed by French press (for E. coli) or 407 
sonication (S. aureus).  Unbroken cells and cellular debris was pelleted by centrifugation at 408 
17,000 g and 4°C for 30 min and the supernatant was retained as the cell lysate. All protein 409 
purification experiments shown in Figs 2c, 2d, 3b, 3f, 3g, S4, S10b, S11 and S12 were 410 
performed at least twice with different biological replicates. 411 
For Ni-affinity purification, 100 µl Ni-NTA resin (Biorad, catalogue number 156-0131) was 412 
equilibrated by washing twice in 1 ml ice cold wash buffer (200 mM NaCl, 15 mM imidazole, 413 
20 mM HEPES, pH 7.2). Cell lysate was diluted to 5 µg/µl protein in ice cold wash buffer (200 414 
mM NaCl, 15 mM imidazole, 20 mM HEPES, pH 7.2) in a final volume of 1.2 ml, added to the 415 
equilibrated Ni-NTA resin and gently agitated for 1 hour at 4°C. The Ni-NTA resin was pelleted 416 
by centrifugation, washed four times with 1 ml ice cold wash buffer  and finally resuspended 417 
in 100 µl elution buffer (200 mM NaCl, 300 mM imidazole, 20 mM HEPES, pH 7.2), mixing at 418 
4°C for 1 hour. The Ni-NTA resin was pelleted, the supernatant carefully removed and retained 419 
as the eluted fraction.   420 
For immunoprecipitation, 40-100 l of Anti-HA Agarose bead suspension (Sigma, catalogue 421 
number A2095) were pelleted, washed twice with PBS and mixed with cell lysate which was 422 
diluted to 5 µg/µl in 200 l PBS. The suspension was incubated with agitation for at least 1 423 
hour at 4°C after which the beads were pelleted and washed four times with 1 ml ice cold wash 424 
17 
 
PBS. After the final wash the supernatant was aspirated to leave ~30 µl of PBS above the 425 
beads for final resuspension.  426 
 427 
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Main text figure legends 609 
Fig 1. EsaD is a substrate of the T7SS. a. The ess locus – genes coding for core components 610 
of the secretion machinery are in green, secreted components yellow and proteins 611 
investigated as part of this study in white. b. and c. EsaD is not required for secretion of EsxA 612 
and EsxC – (b) the RN6390 wild-type or isogenic deletion strains, as indicated, were cultured 613 
in TSB medium to OD600 of 2 or (c) the indicated strains harbouring pRAB11 (empty) or 614 
pRAB11-EsxC were cultured in TSB medium to OD600 of 0.5, then supplemented with ATC 615 
(50ng/ml; to induce plasmid-encoded gene expression) until OD600 of 2. Cells were pelleted 616 
and the supernatant (sn) was retained as the secreted protein fraction. Samples of the 617 
supernatant and whole cells (an equivalent of 200l of culture supernatant and 10l of cells 618 
adjusted to OD1) were separated on 12 % bis-Tris gels and immunoblotted with the indicated 619 
antisera (with TrxA serving as a cytoplasmic control). Note that the samples were run on the 620 
same gel but intervening lanes have been spliced out (unspliced version is shown in Fig S9). 621 
(d) and (e). EsaD is secreted in an essC-dependent manner. The indicated S. aureus strains 622 
harbouring pRAB11 (empty) or pRAB11-EsaD(H528A)-HA were treated as described in (c) 623 
except that 250ng/ml ATC was used to induce EsaD(H528A)-HA production and an equivalent 624 
of 250l of supernatant and 10l of cells adjusted to OD600 of 1 were loaded f. Cells of the wild 625 
type S. aureus strain, RN6390, harbouring pRAB11 or pRAB11-EsaD(H528A)-HA from (d) 626 
were fractionated into cytoplasmic (cyt) and membrane (m) fractions. Samples of each fraction 627 
(20l aliquot of cyt, and 2mg of membrane) were separated on 12% bis-Tris gels and 628 
immunoblotted using either anti-HA, anti-EssB (membrane protein control) or anti-TrxA 629 
(cytoplasmic control) antisera.   630 
 631 
Fig 2. EsaDG form a nuclease toxin-antitoxin pair. a. EsaD is toxic to E. coli. E. coli 632 
BL21(DE3) harbouring pT7.5 (empty vector), pT7.5-esaD(V584Y) or pT7.5-esaDG was 633 
cultured to OD600 0.5, supplemented with 1 mM IPTG (time zero) and OD600 measured at 1 hr 634 
intervals (n=3 biological replicates, error bars are + SD). b. – d. EsaG interacts with the 635 
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nuclease domain of EsaD. b. Interactions between pT25-EsaG and EsaD variants fused to 636 
pT18 assessed by -galactosidase activity assay in E. coli BTH101. BTH101 harbouring pT25 637 
and pT18 was the negative control. Error bars are + SD (n=3 biological replicates). Student’s 638 
t-test gives p values < 0.00001 for EsaD/EsaG and EsaD421-614/EsaG relative to the negative 639 
control. Inset shows the same strain/plasmid combinations on MacConkey maltose plates. c. 640 
and d. Top two panels: S. aureus RN6390 carrying c. pRAB11 (empty vector), pRAB11-EsaG-641 
HA or pRAB11-EsaD(H528A)-His-EsaG-HA, or e. pRAB11 (empty), pRAB11-EsaG-HA, 642 
pRAB11-EsaD421-614(H528A)-His or pRAB11-EsaD421-614(H528A)-His-EsaG-HA was cultured 643 
to OD600 of 0.5, then supplemented with ATC (500ng/ml). Cells were harvested at OD600 3, 644 
lysed and histidine-tagged EsaD purified. Cell lysate (load) and eluted fractions (20l of each) 645 
were analysed by western blot with anti-His and anti-HA antisera. Bottom two panels show 646 
repeat experiments of: c. the EsaD(H528A)-His-EsaG-HA co-purification or d. the EsaD421-647 
614(H528A)-His-EsaG-HA co-purification. Samples of load (10µl), flow through (20µl), final 648 
wash (30µl) and elution fraction (30µl) were analysed using the same antisera. Coomassie-649 
stained samples of the load and elute fractions are shown in Fig S4. e. E. coli M15[prep4] 650 
harbouring pQE70 alone (empty) pQE70-EsaG-EsaG-EsaD421-614-His or pQE70-EsaG-EsaG-651 
EsaD421-614(H528A)-His were cultured to OD600 of 0.5 and supplemented with 1mM IPTG. An 652 
aliquot was harvested after 4 hours’ induction and resuspended in lysis buffer. His-tagged 653 
EsaD nuclease domain (wild type or H528A variant) was purified in the presence of 8M urea, 654 
refolded and eluted as described in Methods. 10µl of each sample were separated (12% bis-655 
Tris gel) and stained using coomassie instant blue. f. EsaD is a Mg2+-dependent DNase. 656 
Plasmid DNA was incubated with purified EsaD421-614-His, EsaD421-614(H528A)-His or buffer 657 
alone with either 50mM MgCl2 or ZnCl2, after which the DNA was analysed by agarose gel 658 
electrophoresis. 659 
 660 
 661 
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Fig 3. EsaE is co-secreted with EsaD and together with EsaG they form a ternary 662 
complex. a – c. EsaE interacts with EsaD. Interactions between a. pT25-EsaD(H528A) and 663 
the indicated fusions to pT18 or c. pT25-EsaE and EsaD1-420 or EsaD421-614(H528A) fused to 664 
pT18 as well as pT18-EsaE and full length EsaD(H528A) fused to pT25 assessed by -665 
galactosidase activity assay in BTH101. BTH101 harbouring pT25 and pT18 was the negative 666 
control. Error bars are + SD (n=3 biological replicates). Student’s t-test gives p values < 667 
0.00001 for EsaD(H528A)/EsaE, EsaD(H528A)/EsaG, EsaD/EsaE, and EsaD1-420/EsaE 668 
relative to the negative control. Inset shows the same strain and plasmid combinations on 669 
MacConkey maltose plates. b. Top two panels - S. aureus RN6390 carrying pRAB11 (empty), 670 
pRAB11-EsaE-HA or pRAB11-EsaD(H528A)-His-EsaE-HA was cultured to OD600 of 0.5 671 
supplemented with 500ng/ml ATC and harvested at OD600 of 3. Cells were lysed and histidine-672 
tagged EsaD(H528A) was purified. Cell lysate (load) and eluted fractions (20l of each) were 673 
analysed by western blot with anti-His and anti-HA antisera. Coomassie-stained samples of 674 
these fractions are shown in Fig S4. Bottom two panels show repeats of EsaD(H528A)-His-675 
EsaE-HA co-purification. Samples of load (10µl), flow through (20µl), final wash (30µl) and 676 
elution fraction (30µl) were analysed using the same antisera. d and e. EsaE is co-secreted 677 
with EsaD. S. aureus RN6390 harbouring pRAB11 (empty) and either d. pRAB11-EsaE-His 678 
or e. pRAB11-EsaD-His-EsaE-HA was cultured to OD600 of 0.5 supplemented with 250ng/ml 679 
ATC and harvested at OD600 of 3. Samples of supernatant and cells (equivalent to 250l 680 
supernatant and 10l cells adjusted to OD600 of 1) were separated on 12% bis-Tris gels and 681 
immunoblotted with the indicated antisera. f. EsaE, EsaD and EsaG form a ternary complex. 682 
E. coli M15[pRep4] carrying pQE70 (empty) or pQE70- EsaE-HA-EsaD(H528A)-Myc-EsaG-683 
His was cultured to OD600 of 0.5, supplemented with 2 mM IPTG for 4 hours, harvested and 684 
lysed. HA-tagged EsaE was purified and 10l, 25l and 35l of the elution fractions were 685 
analysed by western blot with anti-HA, anti-His and anti-myc antibodies, respectively. 686 
Coomassie-stained samples of these fractions are shown in Fig S10. g. Samples of load 687 
(10µl), flow through (20µl), final wash (30µl) and elution fraction (30µl) from the EsaE-HA-688 
24 
 
EsaD(H528A)-Myc-EsaG-His co-purification experiment shown in f. were analysed by western 689 
blotting with the same antisera. 690 
 691 
Fig 4. EsaE is a membrane-associated protein that interacts with multimeric EssC. a. A 692 
proportion of EsaE is bound to the membrane. The S. aureus wild type strain, RN6390, 693 
harbouring pRAB11 (empty) or pRAB11-EsaE-His was cultured in TSB medium to OD600 of 694 
0.5, supplemented with ATC (250ng/ml) and harvested at OD600 of 2. Cells were fractionated 695 
into cell wall (cw), cytoplasmic (cyt) and membrane (m) fractions. An aliquot of the membrane 696 
fraction was washed with 0.2 M Na2CO3 (m+). Samples of each fraction (20l aliquot of cw and 697 
cyt; 2mg of membrane) were separated on 12% bis-Tris gels and immunoblotted using either 698 
anti-His or anti-sortase A (SrtA) antisera. b and c. EsaE crosslinks to a multimeric form of 699 
EssC. b. Whole cells of the S. aureus wild type (RN6390), or c. the wild type and the isogenic 700 
essC deletion strain, as indicated, harbouring pRAB11 (empty) or pRAB11-EsaE-His were 701 
cultured in TSB medium to OD600 of 0.5 supplemented with ATC (250ng/ml) and at OD600 of 702 
2, cells were incubated with paraformaldehyde (PFA) as described under Methods. Following 703 
quenching, cells were lysed and membrane fractions prepared, and membrane protein (1mg 704 
for samples from the wild type strain, 10mg for samples from the essC strain) loaded on b. a 705 
bis-Tris gel containing 12% acrylamide or c. SDS-gels containing 5 % acrylamide (bottom 706 
panel in part C showing EsaE-His monomer is 12% bis-Tris gel) and analysed by western blot 707 
with the indicated antisera. d. Model for EsaD synthesis and secretion. Following synthesis of 708 
EsaD (shown in green), 1 EsaE binds to the N terminal region of the protein and 2 EsaG binds 709 
to the nuclease domain to prevent activity against the DNA of the producing cell. 3 the ternary 710 
complex is targeted to the secretion machinery facilitated by the interaction of EsaE with 711 
multimeric EssC. 4 EsaG is released from EsaD during the transport step and 5 the EsaD-712 
EsaE complex is secreted out of the cell via the T7SS. 713 
 714 
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 715 
Fig 5. Secreted EsaD kills sensitive strains of S. aureus. a. EsaG homologues are encoded 716 
in S. aureus strains that lack esaD. DUF600-family proteins encoded at the ess loci in S. 717 
aureus strains NCTC8325 (parental strain of RN6390), MRSA252, ST398 and EMRSA15. 718 
Genes encoding DUF600 proteins are shaded in purple, essC is shaded green and esaD grey. 719 
The two genes shaded in brown are highly conserved across all strains and define the 3’ 720 
boundary of the ess locus18. b. and c. Interactions between pT25-EsaD(H528A) and DUF600 721 
proteins; b. from strains ST398, MRSA252 and EMRSA15, and c. from strain NCTC8325. In 722 
each case the DUF600 reading frame was fused to pT18 and interaction with full length EsaD 723 
fused to pT25 assessed by -galactosidase activity assay in E. coli BTH101. BTH101 724 
harbouring pT25 and pT18 was the negative control. Error bars are + SD (n=3 biological 725 
replicates). Student’s t-test gives p values < 0.00001 relative to the negative control. Insets 726 
shows the same strain and plasmid combinations on MacConkey maltose plates. d. In vitro 727 
growth competition assays between the indicated attacker and prey strains in liquid medium. 728 
In each case the attacker strain (COL or COLess) overproduced EsaD-HA or EsaD(H528A)-729 
HA along with EsaG-His as described in Methods, and was incubated with either RN6390, 730 
RN639000268-00278 or RN6390 pEsaG-His as prey, as indicated. To the right, the three 731 
prey strains incubated with COL pEsaD-HA-EsaG-His as attacker are replotted next to each 732 
other to allow a more direct comparison. In all experiments five biological replicates of each 733 
attacking strain was used against a single culture of prey. Bars represent the average value 734 
of c.f.u. of prey bacteria at the end of the experiment. Asterisks indicate significant differences 735 
in c.f.u. * p value < 0.05; ** p value < 0.005, *** p value < 0.0005. Comparison of RN6390 with 736 
RN639000268-00278 survival when COL pEsaD-HA-EsaG-His was used as attacker was 737 
not significant (p = 0.069). Error bars are + SD (n = 5 biological replicates).  738 
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Supplementary Figure 1. Localization and predicted topologies of Ess
components in S. aureus strain RN6390. Essential components of the secretion
machinery are shown in green and known secreted substrates in yellow. FHA – forkhead
associated domain. ATP – P-loop ATP-binding domain.
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*Supplementary Figure 2. EsaD has a predicted nuclease domain at its C-terminus. Alignment of S. aureus EsaD with Orthologs
identified using BlastP 10. Multiple sequence alignment was generated using Clustal Omega 11 with default settings. The Streptococcus
pyogenes Spd1 protein, for which nuclease activity has been described 12, was included as a reference for the Endonuclease_NS_2 family
(PFAM 13930). The position of the catalytically active Histidine 121 in Spd1 (H528 for EsaD) is marked with an asterisk. The position of
EsaD V584 that was substituted to a tyrosine in this work is indicated by a red arrow. Abbreviations: Afl, Anoxybacillus flavithermus; Bce,
Bacillus cereus; Bcl, B. clausii; Bha, B. halodurans; Ble, B. lentocellum; Bli, B. licheniformis; Bpu, B. pumilus; Bsu, B. subtilis; Cle,
Clostridium lentocellum; Cpa, Cohnella panacarvi; Sau, Staphylococcus aureus; Sepi, S. epidermidis; Sha, Sediminibacillus halophilus;
Spy, Streptococcus pyogenes; Strep, Streptococcus sp.
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Supplementary Figure 3. Microscopy analysis of E. coli cells producing EsaD. E. coli strain BL21(DE3) harbouring plasmids pT7.5,
pT7.5esaD(V584Y) or pT7.5esaDG was cultured in LB at 37⁰C to OD600 0.5, an aliquot of cells was removed and the remainder of the sample
was supplemented with 1 mM IPTG for a further three hours. a. Cells were analysed by light microscopy and b. The length of the cells was
measured (n=300) and the mean length (+/- one standard deviation) is shown. p<0.001 comparing length of cells harbouring pT7.5esaD(V584Y)
in the presence and the absence of IPTG induction. or c. Cells were treated with the deadend fluorometric TUNEL system kit (Promega) and
analysed by fluorescence light microscopy with a FITC filter. d. EsaD causes DNA damage. BL21(DE3) harbouring the indicated plasmids were
cultured as in a., and cells were harvested prior to IPTG supplementation (0mM IPTG) and after three hour treatment with 1mM IPTG,
deoxynucleotidyl transferase dUTP nick end labelled and fluorescence-positive cells quantified by flow cytometry. The percentage of total cells
that are scored as fluorescence positive is given in the bottom left-hand corner of each panel.
Supplementary Figure 4. Analysis of EsaD(H528A)-His-EsaG-HA, EsaD(H528A)-His-EsaE-
HA and EsaD421-614(H528A)-His-EsaG-HA co-purification by coomassie staining. The S.
aureus wild type strain, RN6390, carrying EsaD(H528A)-His-EsaG-HA, pRAB11-EsaD(H528A)-
His-EsaE-HA or pRAB11-EsaD(H528A)(421-614)-His-EsaG-HA was cultured in TSB medium to
OD600 of 0.5 supplemented with ATC (500ng/ml) and harvested at OD600 of 3. Cells were lysed
and histidine-tagged EsaD(H528A) was purified using nickel affinity beads. The cell lysate (load)
and eluted fractions (20µl aliquots of each) were separated by SDS PAGE (12%) and stained with
coomassie instant blue. The far left hand lane is the molecular weight marker used in the
experiment. Note that these correspond to the same fractions used for western blotting in Fig 2c,
Fig 2d and Fig 3b.
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Supplementary Figure 5. EsaD is a Mg2+-dependent DNase. 200ng of S. aureus
gDNA or 400ng of a linear DNA PCR product were incubated with 0.4 µg purified
EsaD421-614-His, EsaD421-614(H528A)-His or an equivalent volume of elution buffer, each
supplemented with 50 mM MgCl2 in a final volume of 20 l at 37 °C for 20 mins after
which the DNA was analysed by 1% agarose gel electrophoresis.
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Supplementary Figure 6. EsaG is a cytoplasmic protein. The S. aureus wild type strain,
RN6390, harbouring pRAB11 (empty) or pRAB11-EsaG-His was cultured in TSB medium to
OD600 of 0.5, supplemented with ATC (250ng/ml) and harvested at OD600 of 2. A sample of the
supernatant (sn) was retained as the secreted protein fraction and cells were fractionated into
cell wall (cw), cytoplasmic (cyt) and membrane (m) fractions. Samples of each fraction (20l
aliquot of sn, cw, and cyt, 2mg of membrane) were separated on 12% bis-Tris gels and
immunoblotted using either anti-His, anti-EssB (membrane protein control), anti-EsxA or anti-
TrxA (cytoplasmic control) antisera.
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Supplementary Figure 7. EsaG is not co-secreted with EsaD. The S. aureus wild type strain,
RN6390, harbouring pRAB11 (empty) or pRAB11-EsaD(H528A)-HA-EsaG-His were cultured in TSB
medium to OD600 of 0.5, supplemented with ATC (250ng/ml) and harvested at OD600 of 2. Samples of
the supernatant (sn) and cellular (c) fractions (an equivalent of 250l of supernatant and 10l of cells
adjusted to OD600 of 1) were separated on 12% bis-Tris gels and immunoblotted using the indicated
antisera.
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Supplementary Figure 8. EsaD-HA is not detected in the supernatant when esaE or esaG are
deleted. The indicated S. aureus strains harbouring pRAB11 (empty) or pRAB11-EsaD(H528A)-HA
were cultured in TSB medium until to OD600 of 0.5, supplemented with ATC (250ng/ml) and
harvested at OD600 of 2. Samples of the supernatant (sn) and cellular (c) fractions (an equivalent of
250l of supernatant and 10l of cells adjusted to OD600 of 1) were separated on 12% bis-Tris gels
and immunoblotted using the indicated antisera.
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Supplementary Figure 9. EsaD and EsaG proteins are not required for the secretion of EsxA
and EsxC. a. The RN6390 wild-type or isogenic deletion strains, as indicated, were cultured in TSB
medium or b. The indicated strains harbouring pRAB11 (empty) or pRAB11-EsxC were cultured in
TSB medium until an OD600 of 0.5 and supplemented with ATC (50ng/ml). a. and b. When cultures
reached OD600 of 2, cells were spun down and the supernatant (sn) was retained as the secreted
protein fraction, while the pellet was retained as the cellular fraction. Samples of the supernatant and
cellular fractions (an equivalent of 200l of supernatant and 10l of cells adjusted to OD600 of 1)
were separated on 12 % bis-Tris gels and immunoblotted with the indicated antisera.
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Supplementary Figure 10. EsaE and EsaG do not interact with each other. a. Bacterial two-hybrid
analysis of strain BTH101 harbouring pT25 and pT18 (negative), pT25-EsaE and pT18-EsaG, or pT25-
EsaG and pT18-EsaD(H528A) assessed by -galactosidase activity assay. Error bars represent the
standard deviation (n=3 biological replicates). The inset shows the same strain and plasmid
combinations scored on MacConkey maltose plates. b. E. coli strain M15[pRep4] carrying pQE70
(empty) or pQE70-EsaE-HA-EsaG-His was cultured in LB medium to OD600 of 0.5, and then
supplemented with 2 mM IPTG for 4 hours, after which cells were harvested and lysed. His-tagged
EsaG was purified using Ni-affinity beads, and in each case the elution fractions (10l aliquots of each)
were separated by SDS PAGE (12%) and analysed by western blot with anti-HA or anti-His antibodies.
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Supplementary Figure 11. Analysis of EsaE-HA-EsaD(H528A)-Myc-EsaG-His co-purification
by coomassie staining. E. coli M15[pRep4] carrying pQE70 (empty) or pQE70- EsaE-HA-
EsaD(H528A)-Myc-EsaG-His was cultured, lysed and EsaE-HA was purified using anti-HA
antibody-coupled agarose beads as described in Methods and in the legend to Fig 3. The same
samples (10l aliquots of each) as those analysed in Fig 3f were stained using coomassie instant
blue following SDS PAGE (12% bis-Tris gel). The far left hand lane is the molecular weight
marker used in the experiment and the lanes between the load and elute fractions were left
empty.
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Supplementary Figure 12. EsaD, EsaE and EsaG form a ternary complex. E. coli strain
M15[pRep4] carrying pQE70 (empty) or pQE70-EsaE-HA-EsaD(H528A)-Myc-EsaG-His was
cultured in LB medium to OD600 of 0.5, and then supplemented with 2 mM IPTG for 4 hours, after
which cells were harvested and lysed. His-tagged EsaG was purified using Ni-affinity beads, and
20l aliquots the elution fractions (of each) were separated by SDS PAGE (12%) and analysed by
western blot with the indicated antisera. Non-specific bands that cross-react with the anti-Myc
antibody are indicated with asterisks.
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Supplementary Figure 13. Sequence analysis of EsaD proteins shows variability within the C-terminal nuclease domain. EsaD protein
sequences from S. aureus subsp. aureus strains were extracted from the KEGG Genome database (www.genome.jp/kegg/genome.html) and
aligned using Clustal Omega on standard settings. Redundant sequences (100% identity) were omitted for clarity.
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Supplementary Figure 14. Genes encoding additional DUF600 domain proteins are not co-transcribed with esaG and are not
required for EsxA and EsxC secretion. a. Genetic organisation at the 3’ end of the ess locus in S. aureus strain NCTC8325, with
genes encoding DUF600 proteins are shaded in purple. The regions amplified by primer pairs used for RT-PCR analysis (listed in
Table S3) are indicated. b. RT-PCR analysis of mRNA isolated from S. aureus strain RN6390, using primer pairs. The expected sizes
for PCR products 1-3 are 573, 1143 and 684 bp, respectively. c. The RN6390 wild-type or isogenic deletion strains, as indicated, were
cultured in TSB medium to OD600 of 2, cells (c) were harvested and the supernatant (sn) was retained as the secreted protein
fraction. Samples of the supernatant and cellular fractions (an equivalent of 250l of supernatant and 10 l of cells adjusted to OD600
of 1) were separated on 12% bis-Tris gels and immunoblotted using either anti-EsxA, anti-EsxC or anti-TrxA antisera.
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Supplementary Figure 15. Uncropped images of Figs. 1-4 and Supplementary Figs. 5-10, 
12 and 14. 
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Supplementary Figure 16. Synthetic gene sequences used in this study. 
Sequence of insert in pQE70 EsaE-HA-EsaD-Myc-EsaG-His 
GGATCCATGAAAGACGTTAAACGTATCGACTACTTCTCTTACGAAGAACTGACCATCCT
GGGTGGTTCTAAACTGCCGCTGGTTAACTTCGAACTGTTCGACCCGTCTAACTTCGAAG
AAGCGAAAGCGGCGCTGATCGAAAAAGAACTGGTTACCGAAAACGACAAACTGACCGA
CGCGGGTTTCAAAGTTGCGACCCTGGTTCGTGAATACATCTCTGCGATCGTTAACATCC
GTATCAACGACATGTACTTCGCGCCGTTCTCTTACGAAAAAGACGAATACATCCTGCTG
TCTCGTTTCAAAAACAACGGTTTCCAGATCCGTATCATCAACAAAGACATCGCGTGGTG
GTCTATCGTTCAGTCTTACCCGCTGCTGATGCGTCAGGAAAAATCTAACGACTGGGACT
TCAAACAGATCGACGACGAAACCCTGGAAAACCTGAACAACGAATCTATCGACACCATC
GGTCGTGTTCTGGAAATCGAAATCTACAACCACCAGGGTGACCCGCAGCAGTCTCTGT
ACAACATCTACGAACAGAACGACCTGCTGTTCATCCGTTACCCGCTGAAAGACAAAGTT
CTGAACGTTCACATCGGTGTTATCAACACCTTCATCCGTGAACTGTTCGGTTTCGACAC
CGACGAAAACCACATCAACAAAGCGGAAGAATATCCATATGATGTTCCAGATTATGCAT
AATGGATCCATTAAAGAGGAGAAATTAACCATGACCAAAGACATCGAATACCTGACCGC
GGACTACGACAACGAAAAATCTTCTATCCAGTCTGTTATCGACGCGATCGAAGGTCAGG
ACTTCCTGGACGTTGACACCACCATGGACGACGCGGTTTCTGACGTTTCTTCTCTGGAC
GAAGACGGTGCGATCTCTCTGACCTCTTCTGTTGTTGGTCCGCAGGGTTCTAAACTGAT
GGGTTACTACCAGAACGAACTGTACGACTACGCGTCTCAGCTGGACTCTAAAATGAAAG
AAATCATCGACACCCCGTTCATCGAAGACATCGACAAAGCGTTCAAAGGTATCACCAAC
GTTAAACTGGAAAACATCCTGATCAAAAACGGTGGTGGTCACGGTCGTGACACCTACG
GTGCGTCTGGTAAAATCGCGAAAGGTGACGCGAAAAAATCTGACTCTGACGTTTACTCT
ATCGACGAAATCCTGAAATCTGACCAGGAATTCGTTAAAGTTATCGACCAGCACTACAA
AGAAATGAAAAAAGAAGACAAAAAACTGTCTAAATCTGACTTCGAAAAAATGATGACCCA
GGGTGCGTCTTGCGACTACATGACCGTTGCGGAAGCGGAAGAACTGGAAGAACAGAAA
AAAAAAGAAGAAGCGATCGAAATCGCGGCGCTGGCGGGTATGGTTGTTCTGTCTTGCA
TCAACCCGGTTGCGGGTGCGGTTGCGATCGGTGCGTACTCTGCGTACTCTGCGGCGA
ACGCGGCGACCGGTAAAAACATCGTTACCGGTCGTAAACTGTCTAAAGAAGAACGTAT
CATGGAAGGTCTGTCTCTGATCCCGCTGCCGGGTATGGGTTTCCTGAAAGGTGCGGGT
AAATCTCTGATGAAACTGGGTTTCAAAGGTGGTGAAAAATTCGCGGTTAAAACCGGTCT
GCAGAAAACCATGCAGCAGGCGGTTTCTCGTATCTCTCCGAAAATGGGTATGATGAAAA
ACTCTGTTCTGAACCAGTCTCGTAACTTCGCGCAGAACACCCACGTTGGTCAGATGCTG
TCTAACATGCGTGGTCAGGCGACCCACACCGTTCAGCAGTCTCGTAACTGGATCGGTC
AGCAGGCGCAGAACGTTAAACGTATCGTTAACAACGGTCTGGACAAAGAAATCGCGCA
CCCGTTCAAACAGCAGCTGGCGCCGGCGGGTATGGGTGGTATCAAATTCGCGGAAAC
CACCACCCTGCGTAACATGGGTCAGAACATCAAACGTGCGGTTACCCCGCAGAACCAC
GTTACCCACGGTCCGAAAGACTCTATGGTTCGTTCTGAAGGTAAACACTCTATCTCTTC
TCACGAAATGAACTCTTCTAAATACGTTGAATCTCCGAACTACACCAAAGTTGAATTCGG
TGAACACTACGCGCGTCTGCGTCCGAAAAAACTGAAAGCGAACATCGAATACACCACC
CCGACCGGTCACATCTACCGTACCGACCACAAAGGTCGTATCAAAGAAGTTTACGTTGA
CAACCTGTCTCTGAAAGACGGTGACCGTAACTCTCACGCGCAGCGTACCGTTGGTGGT
GAAGACCGTCTGCCGGACGACGACGGTGGTCACCTGATCGCGCGTATGTTCGGTGGT
TCTAAAGACATCGACAACCTGGTTGCGCAGTCTAAATTCATCAACCGTCCGTTCAAAGA
AAAAGGTCACTGGTACAACCTGGAAAAAGAATGGCAGGAATTCCTGAACTCTGGTAAAG
AAGTTAAAAACATCAAAATGGAAGTTAAATACTCTGGTAACTCTCAGCGTCCGACCATCT
TCAAAGTTGAATACGAAATCAACGGTGAACGTAACATCCGTCGTATCCTGAACAAAGAA
CAAAAACTTATTTCTGAAGAAGACCTGTAATATTAAAGAGGAGAAATTAACCATGACCTT
CGAAGAAAAACTGTCTAAAATCTACAACGAAATCGCGAACGAAATCTCTTCTATGATCCC
GGTTGAATGGGAAAAAGTTTACACCATGGCGTACATCGACGACGGTGGTGGTGAAGTT
TTCTTCAACTACACCAAACCGGGTTCTGACGACCTGAACTACTACACCAACATCCCGAA
AGAATACAACATCTCTGTTCAGGTTTTCGACGACCTGTGGATGGACCTGTACGACCTGT
TCGAAGAACTGCGTGACCTGTTCAAAGAAGAAGACCTGGAACCGTGGACCTCTTGCGA
ATTCGACTTCACCCGTGAAGGTGAACTGAAAGTTTCTTTCGACTACATCGACTGGATCA
ACTCTGAATTCGGTCAGATCGGTCGTCAGAACTACTACAAATACCGTAAATTCGGTATC
CTGCCGGAAACCGAATACGAAATCAACAAAGTTAAAGAAATCGAACAGTACATCAAAGA
ACTGGAAAGATCT 
 
Restriction sites are underlined, genes (esaE, esaD and esaG) are shown in italics and added 
tags (HA, Myc) are double underlined. Note that the C-terminal His-tag on EsaG is supplied 
by the vector. 
 
 
Synthetic pT25-DUF600 constructs 
 
pT25-00274 
GGATCCCACTTTCGAAGAAAAATTAAGTGAAATGTATAGCGAGATTGCGAATAAGATTA
GCAGCATGATACCGGTAGAGTGGGAGCAAGTATATGCAATGGCATATGTAACTGATCAA
GCTGGAGAAGTCATCTTTAATTATACTAAACCAGATAGTGATGAATTAAATTATTATTCAG
ACATACCTAAAGATTGCAATGTCTCAAAAGATATTTTTAAGAATTCATGGTTTAAAGTTTA
TCGAATGTTTGATGAGTTAAGAGAAACTTTTAAAGAAGAAGGGCTTGAACCATGGACAT
CATGCGAATTTGACTTTACAAGAGATGGCAAATTGAATGTATCTTTTGATTATATAGATT
GGATAAATACAGAGTTTGATCAATTGGGCCGTCAAAATTATTATATGTACAAAAAATTTG
GGGTTATACCAGAAATGGAATATGAAATGGAAGAAGTTAAAGAAATCGAACAATATATTA
AAGAGCAAGAAGAAGCTGAACAAGGTACC  
 
pT25-00275 
GGATCCCACTTTCGAAGAGAAAATAAGCAAATTATATAATGAGATTGCGAATGAGATTAG
CAGTATGATACCGGTAGAGTGGGAAAAAGTATATACAATGGCTTATATAGATGATGGAG
GAGGTGAAGTATTCTTTAATTATACTAAACCAGGTAGTGATGACTTGAATTATTACACCG
ATATACCTAAGGAGTATAACATCTCTGTGCAAGTATTTGATGATTTATGGATGGATTTAT
ATGATTTGTTTGAGGAATTAAGAGATTTATTTAAAGAAGAAGGGCTTGAACCATGGACAT
CATGTGAATTTGACTTTACAAGCGAAGGTAAATTAAAAGTTTCATTTGATTATATAGATTG
GATAAATACAGAGTTTGATCAATTAGGCCGTGAAAATTATTATATGTATAAAAAATTTGG
GGTTTTACCAGAAATGGAATATGAAATGGAAGAAATTAAAGAAATCGATCAATATATTAA
AGAGCAAGATGAAGCTGAAATAGGTACC  
 
pT25-00276 
GGATCCCACTTTCGAAGAGAAAATAAGCAAATTATATAATGAGATTGCGAATGAGATTAG
CAGTATGATACCGGTAGAGTGGGAAAAAGTATATACAATGGCTTATATAGATGATGGAG
GAGGTGAAGTATTCTTTAATTATACTAAACCAGGAAGTGAAGATTTGAATTATTATACCG
ATATACCTAAGGAGTATAATGTTTCTGTGCAAGTATTTGATGATTTATGGATGGATTTATA
TGATTTGTTTAAGAATTTAAGAAATTTATTTAAAGAAGAAGGACTTGAACCATGGACATC
ATGTGAATTTGACTTTACAAGAGACGGCAAATTGAATGTTTCATTTGATTATATTGATTG
GGCGAATTCAGAGTTTGGACAAATGGGAAGAGAACATTATTACATGTATAAAAAATTTG
GAATTTGGCCTGAAAAAGAATATGCCATAAATTGGGTAAAAAAAATAAAAGATTATGTTA
AAGAGCAAGATGAAGCTGAACTAGGTACC  
 
pT25-00277 
GGATCCCACTTTCGAAGAAAAACTAAGTCAAATGTACAATGAAATTGCAAATGAAATCAG
TGGAATGATACCAGTTGAATGGGAAAATATATATACAATTGCCTATGTAACTGATCAAGG
TGGAGAGGTCATTTTTAATTATACTAAACCAGGTAGCGATGAATTGAATTATTACACATA
TATCCCTAGAGAGTATAATGTCTCTGAAAAAGTATTTTATGATTT 
GTGGACGGATTTATATAGATTGTTTAAGAAGTTAAGAGAAACTTTTAAAGAAGAAGGGCT
TGAACCATGGACATCAAGTGAATTTGACTTTACAAGCGAAGGTAAATTAAAAGTTTCATT
TGATTATATTGATTGGATAAATACAGAGTTTGATCAATTAGGCCGTGAAAACTATTATAT
GTATAAAAAGTTTGGTGTTTTACCAGAAATGGAATACGAAATGGAAGAAGTTAAAGAAAT
CGAGCAATATATTAAAGAGCAAGATGAAGCTGAACTAGGTACC  
 
pT25-00278 
GGATCCCACTTTCGAAGAAAAGCTAAGTCAAATGTACAATGAAATTGCAAATGAAATCA
GTGGAATGATACCAGTAGAATGGGAAAAAGTATATACAATTGCCTACGTAGATGATGAA
GGTGGAGAGGTTGTTTTTAATTATACTAAACCAGGAAGTGAAGATTTGAATTATTATTCA
GATATTCCTAAAGATTGCAATGTCTCAAAAGATATTTTTAAGAATTCATGGTTTAAAGTTT
ATCGAATGTTTGATGAGTTAAGAGAAACTTTTAAAAAAGAAGATTTAGAACCGTGGACAT
CATGTGAATTTGACTTTACAAGAAAGGGAAATTTAAAAGTATCATTTGATTATATAGATTG
GATTAAATTAGGTTTTGGCCCATCAGGAAAGGAAAACTACTATATGTACAAAAAATTTGG
TATTTTACCAGATATGGAATATGAAATGGAAGAAATTCGAGCAGTAGAGAAGTATGTTAA
AGAGCAAGAGGGTACC  
 
pT25-SAPIG0310   
GGATCCCACTTTCGAAGAAAAACTAAGTCAAATGTACAACGAGATTGCGAATGAGATCA
ATGGAATGATACCAGTAGACTGGGAAAAGGTATATGCAATGGCATATATAGATGATGGA
GGAGGAGAAGTGTTCTACTATTACACAGAACCTGGAAGGAATGAATTATACTACTATAC
TAGTGTATTAAATAAATATGATATATCAGAATCAGAATTTATGGACTCAGAGTATGAGTT
GTATAAACAATTTCAAAAGTTAAGAAATATATTTAAAGAAGAAGGACATGAACCATGGAC
ATCATGCGAATTTGATTTTACAAGAGAAGGTAAATTAAAAGTTTCATTTGATTATATAGAT
TGGATAAATTCAGAATTTGGTCAAATAGGTCGACAAAATTACTATAAGTATAGAAAATTT
GGAATTTTACCAGAAACGGAATATGAAATTAATAAAGTTAAAGAAATCGAGCAATATGTT
AAAGAACAAGAAGAAGCTGAAATAGGTACC  
 
pT25-SAPIG0311   
GGATCCCAATTTCGAAGAAAAACTAAGTCAAAAGTACAACGAGATTGCGAATAAAATTA
GTAGCATGATACCAGTAGAGTGGGAAAAGGTATATGCAATGGCTTATATAAATGAAAGA
AATGGAGAAGTTTTCTACAATTATACTGAGCCAAGCAGTGATGAATTGTTTTACTATACG
AGCGTGTTAAATAAATATAATATACCAAGATCAGAATTTATGGACTCAGTATATGAATTAT
ATAAGCAATTTGATAATTTAAGAGAATTGTTTATAGAAGAAGGACTCGAGCCATGGACAT
CATGCGAATTTGACTTTACAAGAGAGGGTAAATTAAACGTATCTTTTGATTATATTGATT
GGACTAAATTAGAATTTGGTCAAATAGCAAAAGAAAATTATTATATGTATAAAAAATTTGG
AGTTATGCCAGAAATGAAATATGAAATTAATAAAGTTAAAGAAGTAGAGAAGTGTATTAA
AGAGCAAGAAGAAGGTACC  
 
pT25-SAPIG0314 
GGATCCCACTTTCGAAGAGAAATTAAGTGAAATGTATAACGAGATTGCGAATGAGATCA
GTGGGATGATACCAGTAGAATGGGAGCAAGTATTTACAATAGCCTATGTAACTGATCAA
GCTGGAGAAGTCATTTTTAATTATACTAAACTGGTAGTGATGAATGGTACC 
 
pT25-SAR0293 
GGATCCCACTTTCGAAGAGAAGTTAAGTCAAATGTACAACGAGATTGCGAATGAGATCA
GTGGGATGATACCGATAGAGTGGGAAAAAGTATATACAATGGCTTATATAGATGATGAA
GGTGGAGAAGTGTTCTACTATTACACAGAACCTGGAAGCAATGAATTATACTACTATACT
AGTGTATTAAATAAATATGATATATCGGAATCAGAATTTATGGACTCAGCGTATGAGTTG
TATAAACAATTTCAAAATTTAAGAAATATATTTAAAGAAGAAGGATATGAACCATGGACAT
CATGCGAATTTGATTTTACAAAAGAAGGTGAATTAAAAGTTTCATTTGATTATATAGATTG
GATCAATACAGAGTTTGATCAATTGGGCCGTCAAAATTATTATATGTACAAAAAATTTGG
GGTTATACCAGAAATGGAATATGAAATGGAAGAAGTTAAAGAAATCGAGCAATATATTAA
AGAGCAAGATGAAGCTGAACAAGGTACC 
 
pT25-SAR0294 
GGATCCCACTTTCGAAGAAAAATTAAGTGAAATGTACAATGAAATTGCGAATAAAATTAG
TAGCATGATACCAGTAGAATGGGAAAAGGTATATACAATGGCTTATATAGATGATGGAG
GAGGTGAAGTATTCTTTAATTATACTAAAATAAACAGCGATGAATTGAATTATTACACCG
ATATACCTAAGGAGTATAACATTTCTGTGCAAGTATTTGATGATTTATGGATGGATTTATA
TGATTTGTTTGAGGAATTAAGAAATTTATTTAAAGAAGAAGGACATGAACCATGGACATC
ATGCGAATTTGATTTTACAAGAGACGGCAAATTGAATGTTTCATTTGATTATATTGATTG
GGCGAATTCAGAGTTTGGGCCAATGGGAAGAGAACATTATTATATGTATAAAAAATTTG
GAATTTGGCCTGAAAAAGAATATGCCATAAATTGGGTTGAAAAAATAAAAGATTATGTTA
AAGAGCAAGAAGAAGCTGAACTAGGTACC  
 
pT25-SAR0295 
GGATCCCACTTTCGAAGAAAAACTAAGTGAAATGTACAACAAGATTGCAAATGAGATTG
TTGGCATGATACCTGTAGAATGGGAAAAGGTATATACAATAGCCTATGTAAATGATAGA
GGTGGAGAGGTCGTTTTTAATTATACTAAACCAGGTAGCGATGAATTGAATTATTACATG
AATATATCTAGAGATTATAATGTTTCGGAAGAAATATTTGATGATTTATGGATGGAACTTT
ATAGATCATTTAAAAAATTAAGAAATATATTTAAAGAAGAAGGACATGAACCATGGACAT
CATGCGAATTTGATTTTACAAACGAAGGTAAATTAAAAGTTTCATTTGATTATATTGATTG
AAAGAATACAGAATTTGATCAATTGAGTCTTGAAAATTATTATATGTACAAAAAATTTGGG
GTTATACCAGAAATGGAAGAAATTAAAGAAATCGAGCAATATATTAAAGAGCAAGAAGAA
GCTGAACTAGGTACC  
 
pT25-SAR0297 
GGATCCCACTTTCGAAGAAAAACAAAGTGAAATGTACAATAAAATTGCAAATGAGATTAG
TGGGATGATACCAGTAGAGTGGGAAAAGGTATATACAATTGCCTACCTAGATGATGAAG
GTGGAGAAGTCGTTTTTAATTATACTAAACCAGGTAGCGATGAATTGAATTATTACACGG
ATATATCTAGAGATTATAATATTTCAGAAAAAATATTTGATGATTTATGGATGAATCTTTAT
TACTTGTTTATGAATTTAAGGGATTTATTTAAATAAGAAGATTTAGAACCATGGACATCAT
GTGAATTTGACTTTACAAGCGAAGGTGATTTAAACGTATCTTTTGATTATATAGATTGGA
TTAAATTAGGTTTTGGCCCATCAGGAAAGGAAAACTACTATATGTATAAAAAGTTTGGTG
TTTTACCAGAAATGGAATATGAAATGGAAGAAATTCGAGCAGTAGAGAAGTATGTTAAA
GAGCAAGAGGGTACC 
 
pT25-SAEMRSA15_02570 
GGATCCCACTTTCGAAGAAAAATTAAGTGAAATGTACAATGAAATTGCGAATGAGATTAG
CAGTATGATACCAGTAGAGTGGGAAAAGGTATATGCAATTGCCTATGTAGATGATCAAG
GTGGAGAGGTCGTTTTTAATTATACAAAACCAGGTAGTGATGAATTGAATTATTACACGA
ATATATCTAGAGGTTATAATGTTTCGGAAGAAATATTTGATGATTTATGGATGAATCTGTA
TTACTTGTTTAAGAATTTAAGGAATTTATTTAAAGAAGAAGGACTCGAACCATGGACATC
ATGCGAATTTGACTTTACAAGAGACGGCAAATTGAAAGTATCATTTGATTATATAGATTG
GATTAATACAGAGTTTGATCAATTGGGCCGTGAAAATTACTATATGTACAAAAAGTTTGG
TGTTTTACCAGAAATGGAATACGAGATGGAAGAAATTAAAGAAATCGAGCAATATATTAA
AGAGCAAGATGAAGCTGAACTAGGTACC 
 
pT25-SAEMRSA15_02580 
GGATCCCACTTTCGAAGAAAAACTAAGTCAAATGTACAACGAGATTGCGAATGAGATTA
GCAGCATGATACCAGTAGAGTGGGAAAAGGTATATGTAATTGCCTATGTAGATGATGGA
GGTGGAGAGGTCATTTTTAATTATACTAAACCAGGTAGCGATGAATTGAATTATTACACA
TATATCCCTAGAGAGTATAATGTCTCTGAAAAAGTATTTTATGATTTGTGGACGGATTTAT
ATAGATTGTTTAAGAAGTTAAGAAATGCATTTAAAGAAGAAGGACTTGAACCATGGACAT
CATGTGAATTTGACTTTGCAAGAGATGGCAAATTAAATGTATCTTTTGATTATATTGATTG
GGTAAATACAGAGTTTGATCAATTGGGCCGTGAAAACTATTATATGTATAAAAAGTTTGG
TGTTTTACCAGAAACGGAATATGAAATGGAAGAAATTCGAGCAGTAGAGAAGTATGTTA
AAGAGCAAGAGGGTACC 
 
Restriction sites are underlined 
 
 
 
ermC integration synthetic construct 
GTCGACGCAGGTAGAGATACAAGAGGATTAATTCGTTTACATCAATTCGATAAAGTGGA
AATGGTACGTTTTGAACAACCTGAAGATTCATGGAATGCTTTAGAAGAAATGACAACAAA
CGCAGAAGCAATTCTAGAAGAGTTAGGTTTACCATACCGTCGTGTTATTTTATGTACAG
GTGATATTGGATTTAGTGCAAGCAAAACATATGATTTAGAAGTTTGGTTACCAAGCTACA
ATGATTATAAAGAAATTAGTTCATGCTCAAACTGTACGGATTTCCAAGCGCGTCGTGCTA
ACATCCGCTTCAAGCGTGACAAAGCAGCTAAACCAGAATTAGCACATACATTAAATGGT
AGTGGTTTAGCAGTTGGACGTACATTTGCTGCTATTGTTGAAAATTACCAAAATGAAGAT
GGAACAGTAACAATTCCAGAAGCATTAGTACCATTTATGGGTGGTAAAACACAAATTTCA
AAACCAGTTAAATAAAGGCTTTAGCTACAAGCTTTAAAAAGTATATATCTACGTATACTTA
AAGCAAGGGCAAGATACTTTAAATAATATTTTAAAAAGTGGTGACGAAGCTGTCGCCAC
TTTTTTTGTGCTGTAAAAATATAATAGTGAGGATGCAGTTGTAAAGGGACAAGAGCTTTG
GTATAATATAAAATTGTGAGTAATAGAATTATTGCTCCTTGCCCATTATGGGCCGCTTAG
TCCAAAAGGAGGTGCAAACAGATGAACGAGAAAAATATAAAACACAGTCAAAACTTTATT
ACTTCAAAACATAATATAGATAAAATAATGACAAATATAAGATTAAATGAACATGATAATA
TCTTTGAAATCGGCTCAGGAAAAGGGCATTTTACCCTTGAATTAGTACAGAGGTGTAATT
TCGTAACTGCCATTGAAATAGACCATAAATTATGCAAAACTACAGAAAATAAACTTGTTG
ATCACGATAATTTCCAAGTTTTAAACAAGGATATATTGCAGTTTAAATTTCCTAAAAACCA
ATCCTATAAAATATTTGGTAATATACCTTATAACATAAGTACGGATATAATACGCAAAATT
GTTTTTGATAGTATAGCTGATGAGATTTATTTAATCGTGGAATACGGGTTTGCTAAAAGA
TTATTAAATACAAAACGCTCATTGGCATTATTTTTAATGGCAGAAGTTGATATTTCTATAT
TAAGTATGGTTCCAAGAGAATATTTTCATCCTAAACCTAAAGTGAATAGCTCACTTATCA
GATTAAATAGAAAAAAATCAAGAATATCACACAAAGATAAACAGAAGTATAATTATTTCGT
TATGAAATGGGTTAACAAAGAATACAAGAAAATATTTACAAAAAATCAATTTAACAATTCC
TTAAAACATGCAGGAATTGACGATTTAAACAATATTAGCTTTGAACAATTCTTATCTCTTT
TCAATAGCTATAAATTATTTAATAAGTAAGTTACAACCAATGACGACTGGGGCATTTCTTT
AATGAATTGCTCCAGTTTTTGTCCAATGCACATAACAACAATAAATTAAGTTTGTGGTTTA
ATGGGGTGAACGCATTTCATTATAGCAACAATACGGGATAATTATGATGAACTAAAACAA
TCTAAAACGTAACAAGTTTGAGCATCACTAATATAGGAAAGGAAGCGATAAAATACTGAT
TTCGTTGATATGTAGTATGAGTTATATCGATGGAGTAGGGTAGGGGGAGGGGATGATTA
TAAGGGAGTGGTACATGAATCAATATCCCAGACTCATCATCAGATATAAAAATTTATAAA
ATTGATACTTAAAAACAACTACAAATCCATAGAAAATATGGAGGTAGTCTTAAATAAAAAA
TTGAAAATTCTCAAAAATAAAAAGTTAATATGAAGCTGACTAAAGACTCCGGAATGTCTA
ACCTCAGACAAACTGATGTCTAATGTTATTGCTTAGGGTATAGAACTGTATTAGACTAGG
TATATTATTTTTTCGTAATTATATAAATATAAAGTGGCAAAGGAGGTAATTGAGATGACAA
CACATTTAAGTTTTAGACAAGGCGTGCAAGAGTGTATCCCAACATTATTGGGTTATGCC
GGTGTTGGTATTTCATTTGGTATTGTGGCTTCGTCTCGAATTC 
 
Restriction sites underlined, ermC sequence in italics, rpsF promoter sequence from B. subtilis 
and trxA rho-independent terminator sequence from S. aureus flanking the ermC gene are 
dashed and the whole integration cassette sandwiched between the homology region (622 bp 
5’, 617 bp 3’) for integration. 
 
 
Synthetic ess region from esxA to esxB, codon optimised for E. coli. 
 
gtcgacATGgcgatgattaaaatgagcccggaagaaattcgcgcgaaaagccagagctatggccagggcagcgatcagat
tcgccagattctgagcgatctgacccgcgcgcagggcgaaattgcggcgaactgggaaggccaggcgtttagccgctttgaag
aacagtttcagcagctgagcccgaaagtggaaaaatttgcgcagctgctggaagaaattaaacagcagctgaacagcaccgc
ggatgcggtgcaggaacaggatcagcagctgagcaacaactttggcctgcagTAAgcattctgaaattggcaaagtcacattt
tctaatgtggctttgcttatcatttttttaagaaaacaactgaaaggaaataagcATGaaaaaaaaaaactggatttatgcgctgat
tgtgaccctgattattattattgcgattgtgagcatgattttttttgtgcagaccaaatatggcgatcagagcgaaaaaggcagccag
agcgtgagcaacaaaaacaacaaaattcatattgcgattgtgaacgaagatcagccgaccacctataacggcaaaaaagtg
gaactgggccaggcgtttattaaacgcctggcgaacgaaaaaaactataaatttgaaaccgtgacccgcaacgtggcggaaa
gcggcctgaaaaacggcggctatcaggtgatgattgtgattccggaaaactttagcaaactggcgatgcagctggatgcgaaa
acgccgagcaaaattagcctgcagtataaaaccgcggtgggccagaaagaagaagtggcgaaaaacaccgaaaaagtgg
tgagcaacgtgctgaacgattttaacaaaaacctggtggaaatttatctgaccagcattattgataacctgcataacgcgcagaa
aaacgtgggcgcgattatgacccgcgaacatggcgtgaacagcaaatttagcaactatctgctgaacccgattaacgattttccg
gaactgtttaccgataccctggtgaacagcattagcgcgaacaaagatattaccaaatggtttcagacctataacaaaagcctgc
tgagcgcgaacagcgatacctttcgcgtgaacaccgattataacgtgagcaccctgattgaaaaacagaacagcctgtttgatg
aacataacaccgcgatggataaaatgctgcaggattataaaagccagaaagatagcgtggaactggataactatattaacgcg
ctgaaacagatggatagccagattgatcagcagagcagtatgcaggataccggcaaagaagaatataaacagaccgtgaaa
gaaaacctggataaactgcgcgaaattattcagagccaggaaagcccgtttagcaaaggcatgattgaagattatcgcaaaca
gctgaccgaaagcctgcaggatgaactggcgaacaacaaagatctgcaggatgcgctgaacagcattaaaatgaacaacgc
gcagtttgcggaaaacctggaaaaacagctgcatgatgatattgtgaaagaaccggataccgataccacctttatttataacatg
agcaaacaggattttattgcggcgggcctgaacgaagatgaagcgaacaaatatgaagcgattgtgaaagaagcgaaacgct
ataaaaacgaatataacctgaaaaaaccgctggcggaacatattaacctgaccgattatgataaccaggtggcgcaggatacc
agcagcctgattaacgatggcgtgaaagtgcagcgcaccgaaaccattaaaagcaacgatattaaccagctgaccgtggcga
ccgatccgcattttaactttgaaggcgatattaaaattaacggcaaaaaatatgatattaaagatcagagcgtgcagctggatacc
agcaacaaagaatataaagtggaagtgaacggcgtggcgaaactgaaaaaagatgcggaaaaagattttctgaaagataaa
accatgcatctgcagctgctgtttggccaggcgaaccgccaggatgaaccgaacgataaaaaagcgaccagcgtggtggatg
tgaccctgaaccataacctggatggccgcctgagcaaagatgcgctgagccagcagctgagcgcgctgagccgctttgatgcg
cattataaaatgtataccgataccaaaggccgcgaagataaaccgtttgataacaaacgcctgattgatatgatggtggatcagg
tgattaacgatatggagagctttaaagatgataaagtggcggtgctgcatcagattgatagcatggaagaaaacagcgataaac
tgattgatgatattctgaacaacaaaaaaaacaccaccaaaaacaaagaagatattagcaaactgattgatcagctggaaaac
gtgaaaaaaacctttgcggaagaaccgcaggaaccgaaaattgataaaggcaaaaacgatgaatttaacaccatgagcagc
aacctggataaagaaattagccgcattagcgaaaaaagcacccagctgctgagcgatacccaggaaagcaaaagcattgcg
gatagcgtgagcggccagctgaaccaggtggataacaacgtgaacaaactgcacgcgacgggccgcgcgctgggcgtgcg
cgcgaacgatctgaaccgccagatggcgaaaaacgataaagataacgaactgtttgcgaaagaatttaaaaaagtgctgcag
aacagcaaagatggcgatcgccagaaccaggcgctgaaagcgtttatgagcaacccggtgcagaaaaaaaacctggaaaa
cgtgctggcgaacaacggcaacaccgatgtgattagcccgaccctgtttgtgctgctgatgtatctgctgagcatgattaccgcgta
tattttttatagctatgaacgcgcgaaaggccagatgaactttattaaagatgattatagcagcaaaaaccatctgtggaacaacgt
gattaccagcggcgtgattggcaccaccggcctggtggaaggcctgattgtgggcctgattgcgatgaacaaatttcatgtgctgg
cgggctatcgcgcgaaatttattctgatggtgattctgaccatgatggtgtttgtgctgattaacacctatctgctgcgccaggtgaaa
agcattggcatgtttctgatgattgcggcgctgggcctgtattttgtggcgatgaacaacctgaaagcggcgggccagggcgtgac
caacaaaattagcccgctgagctatattgataacatgttttttaactatctgaacgcggaacatccgattggcctggtgctggtgattc
tgaccgtgctggtgattattggctttgtgctgaacatgtttattaaacattttaagaaagagagatTAAtctaATGctgatgaacag
cgtgattgcgctgacctttctgaccgcgagcagcaacaacggcggcctgaacattgatgtgcagcaggaagaagaaaaacgc
attaacaacgatctgaaccagtatgataccaccctgtttaacaaagatagcaaagcggtgaacgatgcgattgcgaaacagaa
aaaagaacgccagcagcagattaaaaacgatatgtttcagaaccaggcgagccatagcacccgcctgaacgaaaccaaaa
aagtgctgtttagcaaaagcaacctggaaaaaaccagcgaaagcgataaaagcccgtatattcagaacaaacaggaaaaa
aaaatttttccgtatattctgatgagcgtgggggcttttttgactttaggatTTGtcattttttcaattcataaagggagacgaacgaaa
aatgaatcagcacgtaaaagtaacattTGAttttaccaactataactatggcacctatgatctggcggtgccggcgtatctgccga
ttaaaaacctgattgcgctggtgctggatagcctggatattagcatttttgatgtgaacacccagattaaagtgatgaccaaaggcc
agctgctggtggaaaacgatcgcctgattgattatcagattgcggatggcgatattctgaaactgctgTAGgaggaaaaatagA
TGgtgaaaaaccataacccgaaaaacgaaatgcaggatatgctgaccccgctggatgcggaagaagcggcgaaaaccaa
actgcgcctggatatgcgcgaaattccgaaaagcagcattaaaccggaacattttcatctgatgtatctgctggaacagcatagc
ccgtattttattgatgcggaactgaccgaactgcgcgatagctttcagattcattatgatattaacgataaccataccccgtttgataa
cattaagagctttaccaaaaacgaaaaactgcgctatctgctgaacattaaaaacctggaagaagtgaaccgcacccgctata
cctttgtgctggcgccggatgaactgttttttacccgcgatggcctgccgattgcgaaaacccgcggcctgcagaacgtggttgatc
cgctgccggtgagcgaagcggaatttctgacccgctataaagcgctggtgatttgcgcgtttaacgaaaaacagagctttgatgc
gctggtggaaggcaacctggaactgcataaaggcaccccgtttgaaaccaaagtgattgaagcggcgaccctggatctgctga
ccgcgtttctggatgaacagtatcagaaacaggaacaggattatagccagaactatgcgtatgtgcgcaaagtgggccataccg
tgtttaaatgggtggcgattggcatgaccaccctgagcgtgctgctgattgcgtttctggcgtttctgtattttagcgtgatgaaacata
acgaacgcattgaaaaaggctatcaggcgtttgtgaaagatgattatacccaggtgctgaacacctatgatgatctggatggcaa
aaaactggataaagaagcgctgtatatttatgcgaaaagctatattcagaccaacaaacagggcctggaaaaagataaaaaa
gaaaacctgctgaacaacgtgaccccgaacagcaacaaagattatctgctgtattggatggaactgggccagggccatctgga
tgaagcgattaacattgcgacctatctggatgataacgatattaccaaactggcgctgattaacaaactgaacgaaattaaaaac
aacggcgatctgagcaacgataaacgcagcgaagaaaccaaaaaatataacgataaactgcaggatattctggataaagaa
aaacaggtgaaagatgaaaaagcgaaaagcgaagaagaaaaagcgaaagcgaaagatgaaaaactgaaacagcagg
aagaaaacgaaaaaaaacagaaagaacaggcgcagaaagataaagaaaaacgccaggaagcggaacgcaaaaaaT
AGtataggactgaggcaaagacaATGcataaactgattattaaatataacaaacagctgaaaatgctgaacctgcgcgatg
gcaaaacctataccattagcgaagatgaacgcgcggatattaccctgaaaagcctgggcgaagtgattcatctggaacagaac
aaccagggcacctggcaggcgaaccataccagcattaacaaagtgctggtgcgcaaaggcgatctggatgatattaccctgc
agctgtataccgaagcggattatgcgagctttgcgtatccgagcattcaggataccatgaccattggcccgaacgcgtatgatgat
atggtgattcagagcctgatgaacgcgattattattaaagattttcagagcattcaggaaagccagtatgtgcgcattgtgcatgata
aaaacaccgatgtgtatattaactatgaactgcaggaacagctgaccaacaaagcgtatattggcgatcatatttatgtggaagg
catttggctggaagtgcaggcggatggcctgaacgtgctgagccagaacaccgtggcgagcagcctgattcgcctgacccagg
aaatgccgcacgcgcaggcggatgattataacacctatcatcgcagcccgcgcattattcatcgcgaaccgaccgatgatatta
aaattgaacgcccgccgcagccgattcagaaaaacaacaccgtgatttggcgcagcattattccgccgctggtgatgattgcgct
gaccgtggtgatttttctggtgcgcccgattggcatttatattctgatgatgattggcatgagcaccgtgaccattgtgtttggcattacc
acctattttagcgaaaaaaaaaaatataacaaagatgtggaaaaacgcgaaaaagattataaagcgtatctggataacaaaa
gcaaagaaattaacaaagcgattaaagcgcagcgctttagcctgaactatcattatccgaccgtggcggaaattaaagatattgt
ggaaaccaaagcgccgcgcatttatgaaaaaaccagccatcaccatgattttctgcattataaactgggcattgcgaacgtgga
aaagagctttaaactggattatcaggaagaagaatttaaccagcgccgcgatgaactgtttgatgatgcgaaagaactgtatga
attttataccgatgtggaacaggcgccgctgattaacgatctgaaccacggcccgattgcgtatattggcgcgcgccatctgattct
ggaagaactggaaaaaatgctgattcagctgagcacctttcatagctatcacgatctggaatttctgtttgtgacccgcgaagatg
aagtggaaaccctgaaatgggcgcgctggctgccgcacatgaccctgcgcggccagaacattcgcggctttgtgtataaccag
cgcacccgcgatcagattctgaccagcatttatagcatgattaaagaacgcattcaggcggtgcgcgaacgcagccgcagcaa
cgaacagattatttttaccccgcagctggtgtttgtgattaccgatatgagcctgattattgatcatgtgattctggaatatgtgaacca
ggatctgagcgaatatggcattagcctgatttttgtggaagatgtgattgaaagcctgccggaacatgtggataccattattgatatt
aaaagccgcaccgaaggcgaactgattaccaaagaaaaagaactggtgcagctgaaatttaccccggaaaacattgataac
gtggataaagaatatattgcgcgccgcctggcgaacctgattcatgtggaacatctgaaaaacgcgattccggatagcattacctt
tctggaaatgtataacgtgaaagaagtggatcagctggatgtggtgaaccgctggcgccagaacgaaacctataaaacgatgg
cggtgccgctgggcgtgcgcggcaaagatgatattctgagcctgaacctgcatgaaaaagcgcatggcccgcatggcctggtg
gcgggcaccaccggcagcggcaaaagcgaaattattcagagctatattctgagcctggcgattaactttcatccgcatgaagtg
gcgtttctgctgattgattataaaggcggcggcatggcgaacctgtttaaagatctggtgcatctggtgggcaccattaccaacctg
gatggcgatgaagcgatgcgcgcgctgaccagcattaaagcggaactgcgcaaacgccagcgcctgtttggcgaacatgatg
tgaaccatattaaccagtatcataaactgtttaaagaaggcattgcgaccgaaccgatgccgcatctgtttattattagcgatgaatt
tgcggaactgaaaagcgaacagccggattttatgaaagaactggtgagcaccgcgcgcattggccgcagcctgggcattcatc
tgattctggcgacccagaaaccgagcggcgtggtggatgatcagatttggagcaacagcaaatttaaactggcgctgaaagtg
caggatcgccaggatagcaacgaaattctgaaaaccccggatgcggcggatattaccctgccgggccgcgcgtatctgcaggt
gggcaacaacgaaatttatgaactgtttcagagcgcgtggagcggcgcgacctatgatattgaaggcgataaactggaagtgg
aagataaaaccatttatatgattaacgattatggccagctgcaggcgattaacaaagatctgagcggcctggaagatgaagaaa
ccaaagaaaaccagaccgaactggaagcggtgattgatcatattgaaagcattaccacccgcctggaaattgaagaagtgaa
acgcccgtggctgccgccgctgccggaaaacgtgtatcaggaagatctggtggaaaccgattttcgcaaactgtggagcgatg
atgcgaaagaagtggaactgaccctgggcctgaaagatgtgccggaagaacagtatcagggcccgatggtgctgcagctga
aaaaagcgggccatattgcgctgattggcagtccgggctatggccgcaccacctttctgcataacattatttttgatgtggcgcgcc
atcatcgcccggatcaggcgcacatgtatctgtttgattttggcaccaacggcctgatgccggtgaccgatattccgcatgtggcgg
attattttaccgtggatcaggaagataaaattgcgaaagcgattcgcatttttaacgatgaaattgatcgccgcaaaaaaattctga
gccagtatcgcgtgaccagcattagcgaatatcgcaaactgaccggcgaaaccattccgcatgtgtttattctgattgataactttg
atgcggtgaaagatagcccgtttcaggaagtgtttgaaaacatgatgattaaaatgacccgcgaaggcctggcgctggatatgc
aggtgaccctgaccgcgagccgcgcgaacgcgatgaaaaccccgatgtatattaacatgaaaacccgcattgcgatgtttctgt
atgataaaagcgaagtgagcaacgtggtgggccagcagaaatttgcggtgaaagatgtggtgggccgcgcgctgctgagcag
cgatgataacgtgagctttcatattggccagccgtttaaacatgatgaaaccaaaagctataacgatcagattaacgatgaagtg
agcgcgatgaccgaattttataaaggcgaaaccccgaacgatattccgatgatgccggatgaaattaaatatgaagattatcgc
gaaagcctgaacctgccggatattgtggcgaacggcgcgctgccgattggcctggattatgaaggcgtgaccctgcagaaaatt
aaactgaccgaaccggcgatgattagcagcgaaaacccgcgcgaaattgcgcatattgcggaaattatgatgaaagaaattg
atattctgaacgaaaaatatgcgatttgcattgcggatagcagcggcgaatttaaagcgtatcgccatcaggtggcgaactttgcg
gaagaacgcgaagatattaaagcgattcatcagctgatgattgaagatctgaaacagcgcgaaatggatggcccgtttgaaaa
agatagcctgtatattattaacgattttaaaacctttattgattgcacctatattccggaagatgatgtgaaaaaactgattaccaaag
gcccggaactgggcctgaacattctgtttgtgggcattcataaagaactgattgatgcgtatgataaacagattgatgtggcgcgc
aaaatgattaaccagtttagcattggcattcgcattagcgatcagcagttttttaaatttcgctttattcagcgcgaaccggtgattaaa
gaaaacgaagcgtatatggtggcgaaccaggcgtatcagaaaattcgctggtttaaaTAAcaatgaattaaataggagggag
gtatgttATGaactttaacgatattgaaacgatggtgaaaagcaaatttaaagatattaaaaaacatgcggaagaaattgcgca
tgaaattgaagtgcgcagcggctatctgcgcaaagcggaacagtataaacgcctggaatttaacctgagctttgcgctggatgat
attgaaagcaccgcgaaagatgtgcagaccgcgaaaagcagcgcgaacaaagatagcgtgaccgtgaaaggcaaagcgc
cgaacaccctgtatattgaaaaacgcaacctgatgaaacagaaactggaaatgctgggcgaagatattgataaaaacaaaga
aagcctgcagaaagcgaaagaaattgcgggcgaaaaagcgagcgaatattttaacaaagcgatgaacTAAtattgaggtg
aagatATGggcggctataaaggcattaaagcggatggcggcaaagtggatcaggcgaaacagctggcggcgaaaaccgc
gaaagatattgaagcgtgccagaaacagacccagcagctggcggaatatattgaaggcagcgattgggaaggccagtttgcg
aacaaagtgaaagatgtgctgctgattatggcgaaatttcaggaagaactggtgcagccgatggcggatcatcagaaagcgatt
gataacctgagccagaacctggcgaaatatgataccctgagcattaaacagggcctggatcgcgtgaacccgTAAaagctt 
 
Restriction sites underlined, start and stop codons shown in upper case. 
 
 Supplementary Table 1. Strains used in this study 
Strain Relevant genotype or description  Source or 
reference 
S. aureus strains   
RN6390 NCTC8325 derivative, rbsU, tcaR, cured of φ11, 
φ12, φ13 
Refence1 
∆essC As RN6390, essC  Reference2 
∆ess Complete deletion from esxA – esaG  Reference2 
∆esaE As RN6390, esaD  This work 
∆esaD As RN6390, esaE This work 
∆esaDG As RN6390, esaDG  This work 
∆saouhsc00268-
00278 
As RN6390, esaD-saouhsc00278 This work 
∆saouhsc00274-
00278 
As RN6390, saouhsc00274-saouhsc00278 This work 
RN6390::ermC As RN6390, with ermC resistance gene 
chromosomal insertion  
This work 
∆esaDG::ermC As esaDG with ermC resistance gene from 
RN6390::ermC (phage ɸ11 transduction) 
This work 
∆saouhsc00268-
00278::ermC 
As esaD-saouhsc00278 with ermC resistance 
gene from RN6390::ermC (phage ɸ11 
transduction) 
This work 
∆saouhsc00274-
00278::ermC 
As saouhsc00274-saouhsc00278 with ermC 
resistance gene from RN6390::ermC (phage ɸ11 
transduction) 
This work 
COL MRSA, agr  Reference3 
COLess Complete deletion from Sacol0271 (esxA) -
Sacol0282 
Reference2 
E. coli strains   
JM110 rpsL thr leu thi lacY galK galT ara tonA tsx dam 
dcm glnV44 ∆(lac-proAB) e14- [F’ traD36 proAB+ 
lacIq lacZ∆M15] hsdR17(rK−mK+) 
Stratagene 
BL21(DE3) E. coli B: F-, dcm, ompT, hsdS(rB-, mB-), gal, 
DE3 
Reference4 
 M15 [pREP4] F-, lac, ara, gal, mtl [(KanR, lacI] Qiagen 
BTH101 F- cya-99, araD139, galE15, galK16, rpsL1 (Strr), 
hsdR2, mcrA1, mcrB1 
Reference5 
  
 Supplementary Table 2. Plasmids used in this study 
Plasmid Relevant genotype or description  Source or 
reference 
pIMAY E. coli/S. aureus shuttle vector, temperature 
sensitive, cmlr 
6 
pIMAY-esaE pIMAY carrying esaE deletion allele This work 
pIMAY-esaD pIMAY carrying esaD deletion allele This work 
pIMAY-esaDG pIMAY carrying esaDG deletion allele This work 
pIMAY-
saouhsc00268-00278 
pIMAY carrying esaD-saouhsc00278 deletion 
allele  
This work 
pIMAY-
saouhsc00274-00278 
pIMAY carrying saouhsc00274-saouhsc00278 
deletion allele  
This work 
pRAB11 E. coli/S. aureus shuttle vector, inducible protein 
expression, ampr, cmlr 
Reference7 
pRAB11-
EsaD(H528A)-HA 
pRAB11 producing C-terminally HA-tagged EsaD  This work 
pRAB11-EsaE-his pRAB11 producing C-terminally His-tagged EsaE  This work 
pRAB11-EsaG-his pRAB11 producing C-terminally His-tagged 
EsaG 
This work 
pRAB11-EsaD-His-
EsaG-HA 
pRAB11 producing C-terminally His-tagged EsaD 
and C-terminally HA-tagged EsaG 
This work 
pRAB11-EsaD-HA-
EsaG-His 
pRAB11 producing C-terminally HA-tagged EsaD 
and C-terminally His-tagged EsaG 
This work 
pRAB11-
EsaD(H528A)-His 
pRAB11 producing C-terminally His-tagged 
H528A substituted EsaD 
This work 
pRAB11-EsaG-HA pRAB11 producing C-terminally HA-tagged EsaG This work 
pRAB11-EsaE-HA pRAB11 producing C-terminally HA-tagged EsaE This work 
pRAB11-
EsaD(H528A)-His-
EsaE-HA 
pRAB11 producing C-terminally His-tagged 
H528A substituted EsaD and C-terminally HA-
tagged EsaE 
This work 
pRAB11- 
EsaD(H528A)-HA-
EsaE-His 
pRAB11 producing C-terminally HA-tagged 
H528A-substituted EsaD and C-terminally His-
tagged EsaE 
This work 
pRAB11-EsaD421-614 
(H528A)-His-EsaG-
HA 
pRAB11 producing C-terminally His-tagged 
H528A substituted nuclease domain of EsaD (aa 
421-614and C-terminally HA-tagged EsaG 
This work 
pRAB11-EsaD421-614 
(H528A)-His 
pRAB11 producing C-terminally His-tagged 
H528A substituted nuclease domain of EsaD (aa 
421-614) 
This work 
pRAB11-EsxC pRAB11 producing native (untagged) EsxC This work 
pQE70 Vector for regulatable protein overproduction in 
E. coli (T5 promoter). Ampr 
Qiagen 
pQE70-EsaE-HA- 
EsaD-Myc-EsaG-His1 
pQE70 producing C-terminally HA-tagged EsaE, 
C-terminally Myc-tagged EsaD and C-terminally 
His-tagged EsaG 
This work 
 pQE70-EsaE-HA- 
EsaD(H528A)-Myc-
EsaG-His† 
pQE70 producing C-terminally HA-tagged EsaE, 
C-terminally Myc-tagged H528A-substituted 
EsaD and C-terminally His-tagged EsaG 
This work 
pQE70-EsaE-HA-
EsaG-His 
pQE70 producing C-terminally HA-tagged EsaE 
and C-terminally His-tagged EsaG 
This work 
pQE70-EsaG-EsaG-
EsaD421-614-His 
pQE70 producing tandem copies of EsaG and 
C-terminally His-tagged EsaD421-614 
This work 
pQE70-EsaG-EsaG-
EsaD421-614(H528A)-
His 
pQE70 producing tandem copies of EsaG and 
C-terminally His-tagged H528A substituted 
EsaD421-614 
This work 
pT7.5 Vector for regulatable protein production in E. coli 
(T7 promoter). Ampr 
Reference8 
pT7.5esaD(V584Y) pT7.5 producing V584Y substituted EsaD This work 
pT7.5esaDG pT7.5 producing EsaD and EsaG This work 
pT18 Vector encoding T18 fragment of B. pertussis 
cyaA; Ampr 
Reference9 
pT18-EsaE pT18 carrying esaE This work 
pT18-EsaD(H528A) pT18 carrying esaD (H528A codon substitution) This work 
pT18-EsaD1-420 pT18 carrying esaD (codons 1-420) This work 
pT18-EsaG pT18 carrying esaG This work 
pT25 Vector encoding T18 fragment of B. pertussis 
cyaA; cmlr 
Reference9 
pT25-EsxA pT25 carrying esxA This work 
pT25-EsxB pT25 carrying esxB This work 
pT25-EsaB pT25 carrying esaB This work 
pT25-EsxC pT25 carrying esxC This work 
pT25-EsaE pT25 carrying esaE This work 
pT25-EsaD(H528A) pT25 carrying esaD (H528A codon substitution) This work 
pT25-EsaD421-614 pT25 carrying esaD (codons 421-614, with 
H528A codon substitution) 
This work 
pT25-EsxD pT25 carrying esxD This work 
pT25-EsaG pT25 carrying esaG This work 
pT25-saouhsc00274* pT25 carrying saouhsc00274 This work 
pT25-saouhsc00275* pT25 carrying saouhsc00275 This work 
pT25-saouhsc00276* pT25 carrying saouhsc00276 This work 
 pT25-saouhsc00277* pT25 carrying saouhsc00277 This work 
pT25-saouhsc00278* pT25 carrying saouhsc00278 This work 
pT25-SAPIG0310* pT25 carrying SAPIG0310 This work 
pT25-SAPIG0311* pT25 carrying SAPIG0311 This work 
pT25-SAPIG0314* pT25 carrying SAPIG0314 This work 
pT25-SAR0293* pT25 carrying SAR0293 This work 
pT25-SAR0294* pT25 carrying SAR0294 This work 
pT25-SAR0295* pT25 carrying SAR0295 This work 
pT25-SAR0297* pT25 carrying SAR0297 This work 
pT25-
SAEMRSA15_02570* 
pT25 carrying SAEMRSA15_02570 This work 
pT25-
SAEMRSA15_02580* 
pT25 carrying SAEMRSA15_02580 This work 
†Purchased ready-cloned in the pQE70 vector from Biomatik. 
*Purchased ready-cloned in the pT25 vector from Genescript. 
 
 Supplementary Table 3. Oligonucleotides and cloning strategies used in this study 
Name Nucleotide Sequence (5’-3’) Template Restriction 
Enzyme 
Usage 
EsaE-for-bglII-esxA-
RBS 
GCAGATCTAGGAGGTTTCTACTTATGAAAGATGTT AAGCGAAT gDNA BglII Construction of pRAB11-EsaE-
his1 and pRAB11-EsaE-HA1 
EasE-rev-sacI-HA GCGAGCTCTTATGCATAATCTGGAACATCATATGGATACTCCT 
CTGCTTTATTAATATGAT 
gDNA SacI Construction of pRAB11-EsaE-
HA1 
EasE-rev-sacI-His GCGAGCTCTTAGTGGTGGTGGTGGTGGTGCTCCTCTGCTTTATTA
ATATGAT 
gDNA SacI Construction of pRAB11-EsaE-
his1 
EsaG-for-bgl II GCGCAGATCTAGGAGGTTTCTACTTCAACATGACATTTGAAGAGA gDNA BglII Construction of pRAB11- 
EsaG-his1 and pRAB11-EsaG-
HA1 
esaG-rev-SacI-HA GCGAGCTCTTATGCATAATCTGGAACATCATATGGATATTCTTCTA
GCTCTTTAATATATT 
gDNA SacI Construction of pRAB11-EsaG-
HA1 
esaG-rev-his-EcoRI GCGAATTCTTAGTGGTGGTGGTGGTGGTGTTCTTCTAGCTCTTTAA
TATATT 
gDNA EcoRI Construction of pRAB11-EsaG-
his1 
esaD-kpnI-for-esxA-
RBS 
GAAAGGTACCAGGAGTTTCTACTTATGACAAAAGA 
TATTGAATATCTAAC 
gDNA KpnI Construction of pRAB11-
EsaD(H528A)-his1 and 
pRAB11-EsaD(H528A)-HA1 
esaD-his-to-ala-for CGATGATGGAGGTGCATTAATCGCTAGAATG gDNA  Change of His to Ala codon at 
codon 528 of esaD2 
esaD-his-to-ala-rev CATTCTAGCGATTAATGCACCTCCATCATCG gDNA  Change of His to Ala codon at 
codon 528 of esaD2 
EsaD-his-rev-bgl II  GCGCAGATCTCTAGTGGTGGTGGTGGTGGTGCTTATTTAATATTCT
TCTAATATTTCT 
gDNA/ 
esaD(H528A) 
BglII Construction of pRAB11-
EsaD(H528A)-his1 and 
pRAB11-EsaD421-614(H528A)-
His1 
EsaD-HA-rev-bgl II GCGCAGATCTCTATGCATAATCTGGAACATCATATGGATACTTATTT
AATATTCTTCTAATATTTCT 
gDNA /esaD(H528A) BglII Construction of pRAB11-
EsaD(H528A)-HA1 
 esaD(421-614aa)-kpnI-
for-esxA-RBS 
GAAAGGTACCAGGAGGTTTCTACTTATGACACATGGTCCAAAAGAT
AGTATGGTGAG 
esaD(H528A) KpnI Construction of pRAB11-
EsaD421-614(H528A)-His1 
00268-00278A1 CATGGAGCTCGATTGTACAATC gDNA SacI Construction of pIMAY-
saouhsc_00268-002783  
00268-00278A2 TGTCTGCTACATGTCATGCACCTATCCCTC gDNA  Construction of pIMAY-
saouhsc_00268-002783 
00268-00278B1 CATGACATGTAGCAGACATGTTATAAAAGACTGTG gDNA  Construction of pIMAY-
saouhsc_00268-002783  
00268-00278B2 GCGCGAGCTCCATCTATTTCAGTGTTAATTTAC gDNA SacI Construction of pIMAY-
saouhsc_00268-002783 
00268-00278-out1 TATGTATTTTGCACCATTTAGC   Sequencing primer
00268-00278-out2 CGTTTAAATGTTTGACGCAAGA   Sequencing primer
00274-00278A1 CATGGAGCTCGTATTACATATAGGTGTGGGT gDNA SacI Construction of pIMAY-
saouhsc_00274-002783 
00274-00278A2 TGTCTGCTACATGTTATCGCCCCTATGTGTTGC gDNA  Construction of pIMAY-
saouhsc_00274002783 
00274-00278B1 GATAACATGTAGCAGACATGTTATAAAAGACTGTG gDNA  Construction of pIMAY-
saouhsc_00274-002783 
00274-00278B2 GCGCGGTACCCATCTATTTCAGTGTTAATTTAC gDNA KpnI Construction of pIMAY-
saouhsc_00274-002783 
00274-00278-out1 GGAGCGTTTGCTTTTGTTGTAA gDNA  Sequencing primer 
0266A1        AGGATCCAGTGCTAATAAGGACAGTG gDNA BamHI Construction of pIMAY-esaE3 
0266A2      CTCTGCTTTATCTTTCATCATGGGTTCAC gDNA  Construction of pIMAY-esaE3 
0266B1         ATGAAAGATAAAGCAGAGGAGTAATGACG gDNA  Construction of pIMAY-esaE3 
0266B2   TTCGGATCCAATTGAGATGCATAATC gDNA BamHI Construction of pIMAY-esaE3 
 0268A1      AGAAGGATCCAATGATTGGGACTTTAAAC gDNA BamHI Construction of  pIMAY-esaD3 
and pIMAY-esaDG3 
0268A2         CTTATTTAATTTTGTCATGTCATGCACC gDNA  Construction of pIMAY-esaD3 
and pIMAY-esaDG3 
0268B1        ATGACAAAATTAAATAAGTAGAGGTGCC gDNA  Construction of pIMAY-esaD3 
0268B2       TGAGGATCCACTTTACGGTATCTATTG gDNA BamHI Construction of pIMAY-esaD3  
0269A1         GGTTGAATTCGGAGAACACTATGC gDNA EcoRI Construction of pIMAY-esaG3 
0269A2        TTATTCTTCAAATGTCATGTTGGCACCTC gDNA  Construction of pIMAY-esaD3  
0269B1 ATGACATTTGAAGAATAAACTATCTTAATG gDNA  Construction of pIMAY-esaD3 
and pIMAY-esaDG3 
0269B2       AAAGGATCCATGTTGCAAATACTGCG gDNA BamHI Construction of pIMAY-esaG3 
and pIMAY-esaD3  
EsaG-out1 TGGGTCAAAACATAAAGCGTGC 
 
  Sequencing primer 
EsaG-out2   ACGTGAACATTCCGCCAATTAC 
 
  Sequencing primer 
RT-PCR-primer pair 1-
for 
ACATGGTCCAAAAGATAGTATGGTGAG gDNA  RT-PCR 
RT-PCR-primer pair 1-
rev 
GCACCTCTACTTATTTAATATTCTTC gDNA  RT-PCR 
RT-PCR-primer pair 2-
for 
GAAGAATATTAAATAAGTAGAGGTGC gDNA  RT-PCR 
RT-PCR-primer pair 2-
rev 
GTCATCATCTTCAGTGTTTAATTC gDNA  RT-PCR 
RT-PCR-primer pair 3-
for 
GATACTCTTCGAAAGCCAGGTGCAC gDNA  RT-PCR 
 RT-PCR-primer pair 3-
rev 
GTCATCATCTTCAGTGTTTAATTC gDNA  RT-PCR 
pT25-EsxA-F GCGCGGATCCCGCGATGATTAAAATGAGCCCGGAAG Synthetic esxA gene 
sequence† 
BamHI Construction of pT25-EsxA4 
pT25-EsxA-R GCGCGGTACCTTACTGCAGGCCAAAGTTGTTGCTCAGC Synthetic esxA gene 
sequence† 
KpnI Construction of pT25-EsxA4 
pT25-EsxB-F GCGCGGATCCCGGGCGGCTATAAAGGCATTAAAGC Synthetic esxB gene 
sequence† 
BamHI Construction of pT25-EsxB4 
pT25-EsxB-R GCGCGGTACCTTACGGGTTCACGCGATCCAGGCCCTG Synthetic esxB gene 
sequence† 
KpnI Construction of pT25-EsxB4 
pT25-EsaB-F GCGCGGATCCCAATCAGCACGTAAAAGTAACATTTG 
 
Synthetic esaB gene 
sequence† 
BamHI Construction of pT25-EsaB4 
pT25-EsaB-R GCGCGGTACCTTACAGCAGCAGTTTCAGAATATCGCCATCC Synthetic esaB gene 
sequence† 
KpnI Construction of pT25-EsaB4 
pT25-EsaC-F GCGCGGATCCCAACTTTAACGATATTGAAACGATG Synthetic esxC gene 
sequence† 
BamHI Construction of pT25-EsxC4 
pT25-EsaC-R GCGCGGTACCTTAGTTCATCGCTTTGTTAAAATATTCG Synthetic esxC gene 
sequence† 
KpnI Construction of pT25-EsxC4 
T25esaD-F GCGCGGATCCCACAAAAGATATTGAATATCT esaD(H528A) BamHI Construction of pT25-
EsaD(H528A)4  
T25esaD-R GCGCGGTACCATTACTTATTTAATATTCTTCTAAT esaD(H528A) KpnI Construction of pT25-
EsaD(H528A)4 
T25esaE-F GCGCGGATCCCAAAGATGTTAAGCGAATAGAT gDNA BamHI Construction of pT25-EsaE4  
T25esaE-R GCGCGGTACCATTACTCCTCTGCTTTATTAATAT gDNA KpnI Construction of pT25-EsaE4 
T25esaF-F GCGCGGATCCCACGTTGAGTGGAAAAATTAGTG gDNA BamHI Construction of pT25-EsxD4 
T25esaF-R GCGCGGTACCATTATCCCTCAATATTATAGT gDNA KpnI Construction of pT25-EsxD4 
T25esaG-F GCGCGGATCCCACATTTGAAGAGAAGCTTAG gDNA BamHI 
 
Construction of pT25-EsaG4 
 T25esaG-R GCGCGGTACCATTATTCTTCTAGCTCTTTAATA gDNA KpnI Construction of pT25-EsaG4 
T25esaD-421-614-F GCGCGGATCCCACACATGGTCCAAAAGATAG esaD(H528A) KpnI Construction of pT25-EsaD421-
614(H528A)4 
T18esaD-F GCGCGGGCCCCACAAAAGATATTGAATATCT esaD(H528A) ApaI Construction of pT18-
EsaD(H528A)5  
T18esaD-R GCGCCTCGAGGGCTTATTTAATATTCTTCTAAT esaD(H528A) XhoI Construction of pT18 
EsaD(H528A)5 
T18esaE-F GCGCGGGCCCCAAAGATGTTAAGCGAATAGAT gDNA ApaI Construction of pT18-EsaE5  
T18esaE-R GCGCCTCGAGGGCTCCTCTGCTTTATTAATAT gDNA XhoI Construction of pT18-EsaE5 
T18esaG-F GCGCGGGCCCCACATTTGAAGAGAAGCTTAG gDNA ApaI Construction of pT18-EsaG5 
T18esaG-R GCGCCTCGAGGGTTCTTCTAGCTCTTTAATA gDNA XhoI Construction of pT18-EsaG5 
T18esaD-1-420-R GCGCCTCGAGGGCACGTGATTTTGTGGTGTAACAG gDNA XhoI Construction of pT18-esaD1-4205   
pQE70-esaE-for GCGAGCATGCATGAAAGACGTTAAACGTATC Synthetic esaE gene 
sequence* 
SphI Construction of pQE70-EsaE-
HA-EsaG-his 
pQE70-esaEG-
overlapping-for 
GAAATTAACCATGACCAAAAACAAATAATATTAAAGAGGAGAAATTA
ACCATGACCTTCGAAGAAAAACTGTC 
Synthetic esaEG 
gene sequence* 
 Construction of pQE70-EsaE-
HA-EsaG-his 
pQE70-esaEG-
overlapping-rev 
CATATGATGTTCCAGATTATGCATAATGGATCCATTAAAGAGGAGA
AATTAACCATGACCAAAAACAAATAAT 
Synthetic esaEG 
gene sequence* 
 Construction of pQE70-EsaE-
HA-EsaG-his 
EsaG-for-SphI 
 
GCGAGCATGCCCTTCGAAGAAAAACTGTCTAAAATC Synthetic esaG gene 
sequence* 
SphI Construction of pQE70-EsaG-
EsaG-EsaD421-614-his and 
pQE70-EsaG-EsaG-EsaD421-
614(H528A)-his6 
EsaG-overlapping-for 
 
GTACATCAAAGAA CTGGAATAATAA ATTAAAGAGG 
AGAAATTAACC ATGACCTTCGAAGAAAAACTG 
Synthetic esaG gene 
sequence* 
 Construction of pQE70-EsaG-
EsaG-EsaD421-614-his and 
pQE70-EsaG-EsaG-EsaD421-
614(H528A)-his6 
EsaG-overlapping-rev
  
CAGTTTTTCTTCGAAGGTCATGGTTAATTTCTCCTCTTTAATTTATTA
TTCCAGTTCTTTGATGTAC 
Synthetic esaG gene 
sequence* 
 Construction of pQE70-EsaG-
EsaG-EsaD421-614-his and 
 pQE70-EsaG-EsaG-EsaD421-
614(H528A)-his6 
EsaG-rev-apaI-bamHI 
 
GCGAGGATCCGGGCCCTTATTATTCCAGTTCTTTGATGTACTGTTC
G 
Synthetic esaG gene 
sequence* 
ApaI/BamHI Construction of pQE70-EsaG-
EsaG-EsaD421-614-his and 
pQE70-EsaG-EsaG-EsaD421-
614(H528A)-his6 
EsaDnu-for-ApaI 
 
GCGA GGGCCC ATTAAAGAGGAGAAATTAACCATGCACGGTCCG 
AAAGACTCTATGGTTC 
Synthetic esaD gene 
sequence* 
ApaI 
 
Construction of pQE70-EsaG-
EsaG-EsaD421-614-his and 
pQE70-EsaG-EsaG-EsaD421-
614(H528A)-his6 
EsaDnu-rev-BglII 
 
GCGAAGATCT TTTGTTCAGGATACGACGGATGTTACG Synthetic esaD gene 
sequence* 
BglII Construction of pQE70-EsaG-
EsaG-EsaD421-614-his and 
pQE70-EsaG-EsaG-EsaD421-
614(H528A)-his6 
pQE70-esaD-qc-F ACGACGACGGTGGTGCACTGATCGCGCGTATGTTCGGT Synthetic esaD gene 
sequence* 
 Construction of pQE70-EsaE-
HA-EsaD(H528A)-Myc-EsaG-
his7 
pQE70-esaD-qc-R ACCGAACATACGCGCGATCAGTGCACCACCGTCGTCGT        Synthetic esaD gene 
sequence* 
 Construction of pQE70-EsaE-
HA-EsaD(H528A)-Myc-EsaG-
his7 
pQE70-esaG-rev GCGCAGATCTTTCCAGTTCTTTGATGTACTG Synthetic esaG gene 
sequence* 
BglII Construction of pQE70-EsaE-
HA-EsaG-his 
pT7.5-esaD--for AGTCTAGAAAGCTTTACTATAATATTGAGG gDNA XbaI Construction of pT7.5esaD and 
pT7.5esaDG 
pT7.5-esaD-xhoI-rev CTACTCGAGCTTATTTAATATTCTTCTAAT gDNA XhoI Construction of 
pT7.5esaD(V584Y) 
pT7.5-esaD/G- xhoI-rev  GCCTCGAGTTCTTCTAGCTCTTTAATATATT gDNA XhoI Construction of pT7.5esaDG 
Intctrl1        CCAACTGCTGAAGTACCATTAACG   Checking chromosomal ermC 
integration 
Intctrl2        GTACCTGCTATAAACAACGCGCAC   Checking chromosomal ermC 
integration 
Restriction enzyme sequences are shown in underline. 
 1esaE-His, esaE-HA and esaG-HA were cloned as BglII-SacI fragments, esaG-His was cloned as a BglII-EcoRI fragment and esaD(H528A)-His, esaD(H528A)-HA and 
esaDNuc(aa 421-615; H528A)-His were cloned as KpnI-BglII fragments into similarly digested pRAB11. In each case the forward primer incorporated the esxA ribosome binding 
site (shown in red) to initiate translation. 
2esaD(H528A) was generated by overlapping PCR generating DNA covering the N-terminus of esaD to just beyond codon 528 (amplified with primers esaD-kpnI-for-esxA-RBS 
and esaD-his-to-ala-rev introducing the  H528A substitution) and from just prior to codon 258 to the end of esaD (amplified with primers esaD-his-to-ala-for and EsaD-his-rev-bgl 
II inducing H528A substitution). Subsequently the two fragments were spliced together by overlap PCR using primers esaD-kpnI-for-esxA-RBS and EsaD-his-rev-bgl II. 
3The two flanking regions, upstream and downstream of the gene to be deleted including the first three and last three codons, were separately amplified with the A1/A2 and 
B1/B2 primer pairs. Next, overlapping PCR was performed with the A1 and B2 primers using the amplified flanking regions as template and the product was subsequently cloned 
into PIMAY (as a SacI fragment for the saouhsc_00268-saouhsc_00278 deletion, a SacI-KpnI fragment for the saouhsc_00274-saouhsc_00278 deletion, a BamHI fragment for 
the esaD, esaDG and esaE deletions and an EcoRI-BamHI fragment for the esaG deletion). The primers out1 and out2 were using for sequencing to check the deletions, as 
shown schematically below. 
 
 
 
 
 
4esxA, esxB, esxC, esaB, esaD(H528A), esaD421-614(H528A), esaE, esxD and esaG were each cloned as BamHI-KpnI fragments into similarly digested pT25. 
5esaD(H528A), esaD1-420, esaE, and esaG, were each cloned as ApaI-XhoI fragments into similarly digested pT18. 
†A 10,651bp synthetic DNA sequence coding for EsxA, EsaA, EssA, EssB, EssC EsxC, EsxB from RN6390, codon optimised for expression in E. coli was used as template. The 
sequence of this synthetic DNA is given in Fig S12. 
6Two copies of esaG were amplified, one with primer pair EsaG-for-SphI and EsaG-overlapping-for and the second with primer pair EsaG-overlapping-rev and EsaG-rev-apaI-
bamHI and cloned into pQE70 by three way ligation as an SphI-BamHI fragment. DNA encoding EsaD421-614 or EsaD421-614(H528A) was subsequently cloned into this as 
an ApaI-BglII fragment. 
*A 3,125bp synthetic sequence coding for EsaE, EsaD(H528A) and EsaG. Sequence given in Fig S13. 7The (H528A) substitution of EsaD was introduced into this construct by 
Quickchange using the indicated primers. 
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